203 results on '"C. Livingstone"'
Search Results
2. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
- Author
-
Merricka C. Livingstone, Alexis A. Bitzer, Alish Giri, Kun Luo, Rajeshwer S. Sankhala, Misook Choe, Xiaoyan Zou, S. Moses Dennison, Yuanzhang Li, William Washington, Viseth Ngauy, Georgia D. Tomaras, M. Gordon Joyce, Adrian H. Batchelor, and Sheetij Dutta
- Subjects
Medicine ,Science - Abstract
Abstract Plasmodium falciparum malaria contributes to a significant global disease burden. Circumsporozoite protein (CSP), the most abundant sporozoite stage antigen, is a prime vaccine candidate. Inhibitory monoclonal antibodies (mAbs) against CSP map to either a short junctional sequence or the central (NPNA)n repeat region. We compared in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a recombinant CSP vaccine RTS,S/AS01 (mAbs 317 and 311); an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria (mAbs 580 and 663). RTS,S mAb 317 that specifically binds the (NPNA)n epitope, had the highest affinity and it elicited the best sterile protection in mice. The most potent inhibitor of sporozoite invasion in vitro was mAb CIS43 which shows dual-specific binding to the junctional sequence and (NPNA)n. In vivo mouse protection was associated with the mAb reactivity to the NANPx6 peptide, the in vitro inhibition of sporozoite invasion activity, and kinetic parameters measured using intact mAbs or their Fab fragments. Buried surface area between mAb and its target epitope was also associated with in vivo protection. Association and disconnects between in vitro and in vivo readouts has important implications for the design and down-selection of the next generation of CSP based interventions.
- Published
- 2021
- Full Text
- View/download PDF
3. Retraining walking over ground in a powered exoskeleton after spinal cord injury: a prospective cohort study to examine functional gains and neuroplasticity
- Author
-
Atif S. Khan, Donna C. Livingstone, Caitlin L. Hurd, Jennifer Duchcherer, John E. Misiaszek, Monica A. Gorassini, Patricia J. Manns, and Jaynie F. Yang
- Subjects
Powered exoskeleton ,Spinal cord injury ,Walking ,Rehabilitation ,Locomotion ,Neuroplasticity ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Abstract Background Powered exoskeletons provide a way to stand and walk for people with severe spinal cord injury. Here, we used the ReWalk exoskeleton to determine the training dosage required for walking proficiency, the sensory and motor changes in the nervous system with training, and the functionality of the device in a home-like environment. Methods Participants with chronic (> 1 yr) motor complete or incomplete spinal cord injury, who were primarily wheelchair users, were trained to walk in the ReWalk for 12 weeks. Measures were taken before, during, immediately after, and 2–3 months after training. Measures included walking progression, sitting balance, skin sensation, spasticity, and strength of the corticospinal tracts. Results Twelve participants were enrolled with 10 completing training. Training progression and walking ability: The progression in training indicated about 45 sessions to reach 80% of final performance in training. By the end of training, participants walked at speeds of 0.28–0.60 m/s, and distances of 0.74–1.97 km in 1 h. The effort of walking was about 3.3 times that for manual wheelchair propulsion. One non-walker with an incomplete injury became a walker without the ReWalk after training. Sensory and motor measures: Sitting balance was improved in some, as seen from the limits of stability and sway speed. Neuropathic pain showed no long term changes. Change in spasticity was mixed with suggestion of differences between those with high versus low spasticity prior to training. The strength of motor pathways from the brain to back extensor muscles remained unchanged. Adverse events: Minor adverse events were encountered by the participants and trainer (skin abrasions, non-injurious falls). Field testing: The majority of participants could walk on uneven surfaces outdoors. Some limitations were encountered in home-like environments. Conclusion For individuals with severe SCI, walking proficiency in the ReWalk requires about 45 sessions of training. The training was accompanied by functional improvements in some, especially in people with incomplete injuries. Trial registration NCT02322125 Registered 22 December 2014.
- Published
- 2019
- Full Text
- View/download PDF
4. Human translingual neurostimulation alters resting brain activity in high-density EEG
- Author
-
Zack Frehlick, Bimal Lakhani, Shaun D. Fickling, Ashley C. Livingstone, Yuri Danilov, Jonathan M. Sackier, and Ryan C. N. D’Arcy
- Subjects
Cranial nerve stimulation ,Neuromodulation ,Neuroplasticity ,EEG ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Abstract Background Despite growing evidence of a critical link between neuromodulation technologies and neuroplastic recovery, the underlying mechanisms of these technologies remain elusive. Objective To investigate physiological evidence of central nervous system (CNS) changes in humans during translingual neurostimulation (TLNS). Methods We used high-density electroencephalography (EEG) to measure changes in resting brain activity before, during, and after high frequency (HF) and low frequency (LF) TLNS. Results Wavelet power analysis around Cz and microstate analysis revealed significant changes after 20 min of stimulation compared to baseline. A secondary effect of exposure order was also identified, indicating a differential neuromodulatory influence of HF TLNS relative to LF TLNS on alpha and theta signal power. Conclusions These results further our understanding of the effects of TLNS on underlying resting brain activity, which in the long-term may contribute to the critical link between clinical effect and changes in brain activity.
- Published
- 2019
- Full Text
- View/download PDF
5. Brain Vital Signs Detect Cognitive Improvements During Combined Physical Therapy and Neuromodulation in Rehabilitation From Severe Traumatic Brain Injury: A Case Report
- Author
-
Shaun D. Fickling, Trevor Greene, Debbie Greene, Zack Frehlick, Natasha Campbell, Tori Etheridge, Christopher J. Smith, Fabio Bollinger, Yuri Danilov, Rowena Rizzotti, Ashley C. Livingstone, Bimal Lakhani, and Ryan C. N. D’Arcy
- Subjects
traumatic brain injury (TBI) ,translingual neurostimulation (TLNS) ,electroencephalography (EEG) ,brain vital signs ,neuroplasticity ,post-traumatic stress disorder (PTSD) ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Using a longitudinal case study design, we have tracked the recovery of motor function following severe traumatic brain injury (TBI) through a multimodal neuroimaging approach. In 2006, Canadian Soldier Captain (retired) Trevor Greene (TG) was attacked with an axe to the head while on tour in Afghanistan. TG continues intensive daily rehabilitation, which recently included the integration of physical therapy (PT) with neuromodulation using translingual neurostimulation (TLNS) to facilitate neuroplasticity. Recent findings with PT + TLNS demonstrated that recovery of motor function occurred beyond conventional time limits, currently extending past 14-years post-injury. To investigate whether PT + TLNS similarly resulted in associated cognitive function improvements, we examined event-related potentials (ERPs) with the brain vital signs framework. In parallel with motor function improvements, brain vital signs detected significant increases in basic attention (as measured by P300 response amplitude) and cognitive processing (as measured by contextual N400 response amplitude). These objective cognitive improvements corresponded with TG’s self-reported improvements, including a noteworthy and consistent reduction in ongoing symptoms of post-traumatic stress disorder (PTSD). The findings provide valuable insight into the potential importance of non-invasive neuromodulation in cognitive rehabilitation, in addition to initial indications for physical rehabilitation.
- Published
- 2020
- Full Text
- View/download PDF
6. Searching for Inefficiency in Visual Search.
- Author
-
Gregory J. Christie, Ashley C. Livingstone, and John J. McDonald
- Published
- 2015
- Full Text
- View/download PDF
7. Impact of diabetes on the management and outcomes in atrial fibrillation:an analysis from the ESC-EHRA EORP-AF Long-Term General Registry
- Author
-
Wern Yew Ding, Agnieszka Kotalczyk, Giuseppe Boriani, Francisco Marin, Carina Blomström-Lundqvist, Tatjana S. Potpara, Laurent Fauchier, Gregory.Y.H. Lip, G. Boriani, G.Y.H. Lip, L. Tavazzi, A.P. Maggioni, G.-A. Dan, T. Potpara, M. Nabauer, F. Marin, Z. Kalarus, A. Goda, G. Mairesse, T. Shalganov, L. Antoniades, M. Taborsky, S. Riahi, P. Muda, I. García Bolao, O. Piot, K. Etsadashvili, E. Simantirakis, M. Haim, A. Azhari, J. Najafian, M. Santini, E. Mirrakhimov, K.A. Kulzida, A. Erglis, L. Poposka, M. Burg, H. Crijns, Ö. Erküner, D. Atar, R. Lenarczyk, M. Martins Oliveira, D. Shah, E. Serdechnaya, E. Diker, D. Lane, E. Zëra, U. Ekmekçiu, V. Paparisto, M. Tase, H. Gjergo, J. Dragoti, M. Ciutea, N. Ahadi, Z. el Husseini, M. Raepers, J. Leroy, P. Haushan, A. Jourdan, C. Lepiece, L. Desteghe, J. Vijgen, P. Koopman, G. Van Genechten, H. Heidbuchel, T. Boussy, M. De Coninck, H. Van Eeckhoutte, N. Bouckaert, A. Friart, J. Boreux, C. Arend, P. Evrard, L. Stefan, E. Hoffer, J. Herzet, M. Massoz, C. Celentano, M. Sprynger, L. Pierard, P. Melon, B. Van Hauwaert, C. Kuppens, D. Faes, D. Van Lier, A. Van Dorpe, A. Gerardy, O. Deceuninck, O. Xhaet, F. Dormal, E. Ballant, D. Blommaert, D. Yakova, M. Hristov, T. Yncheva, N. Stancheva, S. Tisheva, M. Tokmakova, F. Nikolov, D. Gencheva, B. Kunev, M. Stoyanov, D. Marchov, V. Gelev, V. Traykov, A. Kisheva, H. Tsvyatkov, R. Shtereva, S. Bakalska-Georgieva, S. Slavcheva, Y. Yotov, M. Kubíčková, A. Marni Joensen, A. Gammelmark, L. Hvilsted Rasmussen, P. Dinesen, S. Krogh Venø, B. Sorensen, A. Korsgaard, K. Andersen, C. Fragtrup Hellum, A. Svenningsen, O. Nyvad, P. Wiggers, O. May, A. Aarup, B. Graversen, L. Jensen, M. Andersen, M. Svejgaard, S. Vester, S. Hansen, V. Lynggaard, M. Ciudad, R. Vettus, A. Maestre, S. Castaño, S. Cheggour, J. Poulard, V. Mouquet, S. Leparrée, J. Bouet, J. Taieb, A. Doucy, H. Duquenne, A. Furber, J. Dupuis, J. Rautureau, M. Font, P. Damiano, M. Lacrimini, J. Abalea, S. Boismal, T. Menez, J. Mansourati, G. Range, H. Gorka, C. Laure, C. Vassalière, N. Elbaz, N. Lellouche, K. Djouadi, F. Roubille, D. Dietz, J. Davy, M. Granier, P. Winum, C. Leperchois-Jacquey, H. Kassim, E. Marijon, J. Le Heuzey, J. Fedida, C. Maupain, C. Himbert, E. Gandjbakhch, F. Hidden-Lucet, G. Duthoit, N. Badenco, T. Chastre, X. Waintraub, M. Oudihat, J. Lacoste, C. Stephan, H. Bader, N. Delarche, L. Giry, D. Arnaud, C. Lopez, F. Boury, I. Brunello, M. Lefèvre, R. Mingam, M. Haissaguerre, M. Le Bidan, D. Pavin, V. Le Moal, C. Leclercq, T. Beitar, I. Martel, A. Schmid, N. Sadki, C. Romeyer-Bouchard, A. Da Costa, I. Arnault, M. Boyer, C. Piat, N. Lozance, S. Nastevska, A. Doneva, B. Fortomaroska Milevska, B. Sheshoski, K. Petroska, N. Taneska, N. Bakrecheski, K. Lazarovska, S. Jovevska, V. Ristovski, A. Antovski, E. Lazarova, I. Kotlar, J. Taleski, S. Kedev, N. Zlatanovik, S. Jordanova, T. Bajraktarova Proseva, S. Doncovska, D. Maisuradze, A. Esakia, E. Sagirashvili, K. Lartsuliani, N. Natelashvili, N. Gumberidze, R. Gvenetadze, N. Gotonelia, N. Kuridze, G. Papiashvili, I. Menabde, S. Glöggler, A. Napp, C. Lebherz, H. Romero, K. Schmitz, M. Berger, M. Zink, S. Köster, J. Sachse, E. Vonderhagen, G. Soiron, K. Mischke, R. Reith, M. Schneider, W. Rieker, D. Boscher, A. Taschareck, A. Beer, D. Oster, O. Ritter, J. Adamczewski, S. Walter, A. Frommhold, E. Luckner, J. Richter, M. Schellner, S. Landgraf, S. Bartholome, R. Naumann, J. Schoeler, D. Westermeier, F. William, K. Wilhelm, M. Maerkl, R. Oekinghaus, M. Denart, M. Kriete, U. Tebbe, T. Scheibner, M. Gruber, A. Gerlach, C. Beckendorf, L. Anneken, M. Arnold, S. Lengerer, Z. Bal, C. Uecker, H. Förtsch, S. Fechner, V. Mages, E. Martens, H. Methe, T. Schmidt, B. Schaeffer, B. Hoffmann, J. Moser, K. Heitmann, S. Willems, C. Klaus, I. Lange, M. Durak, E. Esen, F. Mibach, H. Mibach, A. Utech, M. Gabelmann, R. Stumm, V. Ländle, C. Gartner, C. Goerg, N. Kaul, S. Messer, D. Burkhardt, C. Sander, R. Orthen, S. Kaes, A. Baumer, F. Dodos, A. Barth, G. Schaeffer, J. Gaertner, J. Winkler, A. Fahrig, J. Aring, I. Wenzel, S. Steiner, A. Kliesch, E. Kratz, K. Winter, P. Schneider, A. Haag, I. Mutscher, R. Bosch, J. Taggeselle, S. Meixner, A. Schnabel, A. Shamalla, H. Hötz, A. Korinth, C. Rheinert, G. Mehltretter, B. Schön, N. Schön, A. Starflinger, E. Englmann, G. Baytok, T. Laschinger, G. Ritscher, A. Gerth, D. Dechering, L. Eckardt, M. Kuhlmann, N. Proskynitopoulos, J. Brunn, K. Foth, C. Axthelm, H. Hohensee, K. Eberhard, S. Turbanisch, N. Hassler, A. Koestler, G. Stenzel, D. Kschiwan, M. Schwefer, S. Neiner, S. Hettwer, M. Haeussler-Schuchardt, R. Degenhardt, S. Sennhenn, M. Brendel, A. Stoehr, W. Widjaja, S. Loehndorf, A. Logemann, J. Hoskamp, J. Grundt, M. Block, R. Ulrych, A. Reithmeier, V. Panagopoulos, C. Martignani, D. Bernucci, E. Fantecchi, I. Diemberger, M. Ziacchi, M. Biffi, P. Cimaglia, J. Frisoni, I. Giannini, S. Boni, S. Fumagalli, S. Pupo, A. Di Chiara, P. Mirone, F. Pesce, C. Zoccali, V.L. Malavasi, A. Mussagaliyeva, B. Ahyt, Z. Salihova, K. Koshum-Bayeva, A. Kerimkulova, A. Bairamukova, B. Lurina, R. Zuzans, S. Jegere, I. Mintale, K. Kupics, K. Jubele, O. Kalejs, K. Vanhear, M. Cachia, E. Abela, S. Warwicker, T. Tabone, R. Xuereb, D. Asanovic, D. Drakalovic, M. Vukmirovic, N. Pavlovic, L. Music, N. Bulatovic, A. Boskovic, H. Uiterwaal, N. Bijsterveld, J. De Groot, J. Neefs, N. van den Berg, F. Piersma, A. Wilde, V. Hagens, J. Van Es, J. Van Opstal, B. Van Rennes, H. Verheij, W. Breukers, G. Tjeerdsma, R. Nijmeijer, D. Wegink, R. Binnema, S. Said, S. Philippens, W. van Doorn, T. Szili-Torok, R. Bhagwandien, P. Janse, A. Muskens, M. van Eck, R. Gevers, N. van der Ven, A. Duygun, B. Rahel, J. Meeder, A. Vold, C. Holst Hansen, I. Engset, B. Dyduch-Fejklowicz, E. Koba, M. Cichocka, A. Sokal, A. Kubicius, E. Pruchniewicz, A. Kowalik-Sztylc, W. Czapla, I. Mróz, M. Kozlowski, T. Pawlowski, M. Tendera, A. Winiarska-Filipek, A. Fidyk, A. Slowikowski, M. Haberka, M. Lachor-Broda, M. Biedron, Z. Gasior, M. Kołodziej, M. Janion, I. Gorczyca-Michta, B. Wozakowska-Kaplon, M. Stasiak, P. Jakubowski, T. Ciurus, J. Drozdz, M. Simiera, P. Zajac, T. Wcislo, P. Zycinski, J. Kasprzak, A. Olejnik, E. Harc-Dyl, J. Miarka, M. Pasieka, M. Ziemińska-Łuć, W. Bujak, A. Śliwiński, A. Grech, J. Morka, K. Petrykowska, M. Prasał, G. Hordyński, P. Feusette, P. Lipski, A. Wester, W. Streb, J. Romanek, P. Woźniak, M. Chlebuś, P. Szafarz, W. Stanik, M. Zakrzewski, J. Kaźmierczak, A. Przybylska, E. Skorek, H. Błaszczyk, M. Stępień, S. Szabowski, W. Krysiak, M. Szymańska, J. Karasiński, J. Blicharz, M. Skura, K. Hałas, L. Michalczyk, Z. Orski, K. Krzyżanowski, A. Skrobowski, L. Zieliński, M. Tomaszewska-Kiecana, M. Dłużniewski, M. Kiliszek, M. Peller, M. Budnik, P. Balsam, G. Opolski, A. Tymińska, K. Ozierański, A. Wancerz, A. Borowiec, E. Majos, R. Dabrowski, H. Szwed, A. Musialik-Lydka, A. Leopold-Jadczyk, E. Jedrzejczyk-Patej, M. Koziel, M. Mazurek, K. Krzemien-Wolska, P. Starosta, E. Nowalany-Kozielska, A. Orzechowska, M. Szpot, M. Staszel, S. Almeida, H. Pereira, L. Brandão Alves, R. Miranda, L. Ribeiro, F. Costa, F. Morgado, P. Carmo, P. Galvao Santos, R. Bernardo, P. Adragão, G. Ferreira da Silva, M. Peres, M. Alves, M. Leal, A. Cordeiro, P. Magalhães, P. Fontes, S. Leão, A. Delgado, A. Costa, B. Marmelo, B. Rodrigues, D. Moreira, J. Santos, L. Santos, A. Terchet, D. Darabantiu, S. Mercea, V. Turcin Halka, A. Pop Moldovan, A. Gabor, B. Doka, G. Catanescu, H. Rus, L. Oboroceanu, E. Bobescu, R. Popescu, A. Dan, A. Buzea, I. Daha, G. Dan, I. Neuhoff, M. Baluta, R. Ploesteanu, N. Dumitrache, M. Vintila, A. Daraban, C. Japie, E. Badila, H. Tewelde, M. Hostiuc, S. Frunza, E. Tintea, D. Bartos, A. Ciobanu, I. Popescu, N. Toma, C. Gherghinescu, D. Cretu, N. Patrascu, C. Stoicescu, C. Udroiu, G. Bicescu, V. Vintila, D. Vinereanu, M. Cinteza, R. Rimbas, M. Grecu, A. Cozma, F. Boros, M. Ille, O. Tica, R. Tor, A. Corina, A. Jeewooth, B. Maria, C. Georgiana, C. Natalia, D. Alin, D. Dinu-Andrei, M. Livia, R. Daniela, R. Larisa, S. Umaar, T. Tamara, M. Ioachim Popescu, D. Nistor, I. Sus, O. Coborosanu, N. Alina-Ramona, R. Dan, L. Petrescu, G. Ionescu, C. Vacarescu, E. Goanta, M. Mangea, A. Ionac, C. Mornos, D. Cozma, S. Pescariu, E. Solodovnicova, I. Soldatova, J. Shutova, L. Tjuleneva, T. Zubova, V. Uskov, D. Obukhov, G. Rusanova, N. Isakova, S. Odinsova, T. Arhipova, E. Kazakevich, O. Zavyalova, T. Novikova, I. Riabaia, S. Zhigalov, E. Drozdova, I. Luchkina, Y. Monogarova, D. Hegya, L. Rodionova, V. Nevzorova, O. Lusanova, A. Arandjelovic, D. Toncev, L. Vukmirovic, M. Radisavljevic, M. Milanov, N. Sekularac, M. Zdravkovic, S. Hinic, S. Dimkovic, T. Acimovic, J. Saric, S. Radovanovic, A. Kocijancic, B. Obrenovic-Kircanski, D. Kalimanovska Ostric, D. Simic, I. Jovanovic, I. Petrovic, M. Polovina, M. Vukicevic, M. Tomasevic, N. Mujovic, N. Radivojevic, O. Petrovic, S. Aleksandric, V. Kovacevic, Z. Mijatovic, B. Ivanovic, M. Tesic, A. Ristic, B. Vujisic-Tesic, M. Nedeljkovic, A. Karadzic, A. Uscumlic, M. Prodanovic, M. Zlatar, M. Asanin, B. Bisenic, V. Vasic, Z. Popovic, D. Djikic, M. Sipic, V. Peric, B. Dejanovic, N. Milosevic, S. Backovic, A. Stevanovic, A. Andric, B. Pencic, M. Pavlovic-Kleut, V. Celic, M. Pavlovic, M. Petrovic, M. Vuleta, N. Petrovic, S. Simovic, Z. Savovic, S. Milanov, G. Davidovic, V. Iric-Cupic, D. Djordjevic, M. Damjanovic, S. Zdravkovic, V. Topic, D. Stanojevic, M. Randjelovic, R. Jankovic-Tomasevic, V. Atanaskovic, S. Antic, D. Simonovic, M. Stojanovic, S. Stojanovic, V. Mitic, V. Ilic, D. Petrovic, M. Deljanin Ilic, S. Ilic, V. Stoickov, S. Markovic, A. Mijatovic, D. Tanasic, G. Radakovic, J. Peranovic, N. Panic-Jelic, O. Vujadinovic, P. Pajic, S. Bekic, S. Kovacevic, A. García Fernandez, A. Perez Cabeza, M. Anguita, L. Tercedor Sanchez, E. Mau, J. Loayssa, M. Ayarra, M. Carpintero, I. Roldán Rabadan, M. Gil Ortega, A. Tello Montoliu, E. Orenes Piñero, S. Manzano Fernández, F. Marín, A. Romero Aniorte, A. Veliz Martínez, M. Quintana Giner, G. Ballesteros, M. Palacio, O. Alcalde, I. García-Bolao, V. Bertomeu Gonzalez, F. Otero-Raviña, J. García Seara, J. Gonzalez Juanatey, N. Dayal, P. Maziarski, P. Gentil-Baron, M. Koç, E. Onrat, I.E. Dural, K. Yilmaz, B. Özin, S. Tan Kurklu, Y. Atmaca, U. Canpolat, L. Tokgozoglu, A.K. Dolu, B. Demirtas, D. Sahin, O. Ozcan Celebi, G. Gagirci, U.O. Turk, H. Ari, N. Polat, N. Toprak, M. Sucu, O. Akin Serdar, A. Taha Alper, A. Kepez, Y. Yuksel, A. Uzunselvi, S. Yuksel, M. Sahin, O. Kayapinar, T. Ozcan, H. Kaya, M.B. Yilmaz, M. Kutlu, M. Demir, C. Gibbs, S. Kaminskiene, M. Bryce, A. Skinner, G. Belcher, J. Hunt, L. Stancombe, B. Holbrook, C. Peters, S. Tettersell, A. Shantsila, K. Senoo, M. Proietti, K. Russell, P. Domingos, S. Hussain, J. Partridge, R. Haynes, S. Bahadur, R. Brown, S. McMahon, J. McDonald, K. Balachandran, R. Singh, S. Garg, H. Desai, K. Davies, W. Goddard, G. Galasko, I. Rahman, Y. Chua, O. Payne, S. Preston, O. Brennan, L. Pedley, C. Whiteside, C. Dickinson, J. Brown, K. Jones, L. Benham, R. Brady, L. Buchanan, A. Ashton, H. Crowther, H. Fairlamb, S. Thornthwaite, C. Relph, A. McSkeane, U. Poultney, N. Kelsall, P. Rice, T. Wilson, M. Wrigley, R. Kaba, T. Patel, E. Young, J. Law, C. Runnett, H. Thomas, H. McKie, J. Fuller, S. Pick, A. Sharp, A. Hunt, K. Thorpe, C. Hardman, E. Cusack, L. Adams, M. Hough, S. Keenan, A. Bowring, J. Watts, J. Zaman, K. Goffin, H. Nutt, Y. Beerachee, J. Featherstone, C. Mills, J. Pearson, L. Stephenson, S. Grant, A. Wilson, C. Hawksworth, I. Alam, M. Robinson, S. Ryan, R. Egdell, E. Gibson, M. Holland, D. Leonard, B. Mishra, S. Ahmad, H. Randall, J. Hill, L. Reid, M. George, S. McKinley, L. Brockway, W. Milligan, J. Sobolewska, J. Muir, L. Tuckis, L. Winstanley, P. Jacob, S. Kaye, L. Morby, A. Jan, T. Sewell, C. Boos, B. Wadams, C. Cope, P. Jefferey, N. Andrews, A. Getty, A. Suttling, C. Turner, K. Hudson, R. Austin, S. Howe, R. Iqbal, N. Gandhi, K. Brophy, P. Mirza, E. Willard, S. Collins, N. Ndlovu, E. Subkovas, V. Karthikeyan, L. Waggett, A. Wood, A. Bolger, J. Stockport, L. Evans, E. Harman, J. Starling, L. Williams, V. Saul, M. Sinha, L. Bell, S. Tudgay, S. Kemp, L. Frost, T. Ingram, A. Loughlin, C. Adams, M. Adams, F. Hurford, C. Owen, C. Miller, D. Donaldson, H. Tivenan, H. Button, A. Nasser, O. Jhagra, B. Stidolph, C. Brown, C. Livingstone, M. Duffy, P. Madgwick, P. Roberts, E. Greenwood, L. Fletcher, M. Beveridge, S. Earles, D. McKenzie, D. Beacock, M. Dayer, M. Seddon, D. Greenwell, F. Luxton, F. Venn, H. Mills, J. Rewbury, K. James, K. Roberts, L. Tonks, D. Felmeden, W. Taggu, A. Summerhayes, D. Hughes, J. Sutton, L. Felmeden, M. Khan, E. Walker, L. Norris, L. O'Donohoe, A. Mozid, H. Dymond, H. Lloyd-Jones, G. Saunders, D. Simmons, D. Coles, D. Cotterill, S. Beech, S. Kidd, B. Wrigley, S. Petkar, A. Smallwood, R. Jones, E. Radford, S. Milgate, S. Metherell, V. Cottam, C. Buckley, A. Broadley, D. Wood, J. Allison, K. Rennie, L. Balian, L. Howard, L. Pippard, S. Board, T. Pitt-Kerby, Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Océan du Large et Variabilité Climatique (OLVAC), Laboratoire d'études en Géophysique et océanographie spatiales (LEGOS), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut national des sciences de l'Univers (INSU - CNRS)-Observatoire Midi-Pyrénées (OMP), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Institut de Recherche pour le Développement (IRD)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Institut de Recherche pour le Développement (IRD)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Centre National de la Recherche Scientifique (CNRS), Uppsala University, University of Belgrade [Belgrade], CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Éducation Éthique Santé EA 7505 (EES), and Université de Tours (UT)
- Subjects
Kardiologi ,General Practice ,Cohort ,Anticoagulants ,MACE ,Endocrinology and Diabetes ,Prognosis ,[SHS]Humanities and Social Sciences ,Allmänmedicin ,Stroke ,Risk Factors ,Healthcare resource utilisation ,Mortality ,Prevalence ,Endokrinologi och diabetes ,Atrial Fibrillation ,Internal Medicine ,Diabetes Mellitus ,Quality of Life ,Humans ,Cardiac and Cardiovascular Systems ,Prospective Studies ,Registries ,Aged - Abstract
BACKGROUND: The prevalence of atrial fibrillation(AF) and diabetes mellitus is rising to epidemic proportions. We aimed to assess the impact of diabetes on the management and outcomes of patients with AF.METHODS: The EORP-AF General Long-Term Registry is a prospective, observational registry from 250 centres across 27 European countries. Outcomes of interest were as follows: i)rhythm control interventions; ii)quality of life; iii)healthcare resource utilisation; and iv)major adverse events.RESULTS: Of 11,028 patients with AF, the median age was 71 (63-77) years and 2537 (23.0%) had diabetes. Median follow-up was 24 months. Diabetes was related to increased use of anticoagulation but less rhythm control interventions. Using multivariable analysis, at 2-year follow-up, patients with diabetes were associated with greater levels of anxiety (p = 0.038) compared to those without diabetes. Overall, diabetes was associated with worse health during follow-up, as indicated by Health Utility Score and Visual Analogue Scale. Healthcare resource utilisation was greater with diabetes in terms of length of hospital stay (8.1 (±8.2) vs. 6.1 (±6.7) days); cardiology and internal medicine/general practitioner visits; and emergency room admissions. Diabetes was an independent risk factor of major adverse cardiovascular event (MACE; HR 1.26 [95% CI, 1.04-1.52]), all-cause mortality (HR 1.28 [95% CI, 1.08-1.52]), and cardiovascular mortality (HR 1.41 [95% CI, 1.09-1.83]).CONCLUSION: In this contemporary AF cohort, diabetes was present in 1 in 4 patients and it served as an independent risk factor for reduced quality of life, greater healthcare resource utilisation and excess MACE, all-cause mortality and cardiovascular mortality. There was increased use of anticoagulation therapy in diabetes but with less rhythm control interventions.
- Published
- 2022
- Full Text
- View/download PDF
8. Evaluating the evidence for ecological effectiveness of South Africa’s marine protected areas
- Author
-
Kerry Sink, George M. Branch, L Williams, SP Kirkman, Robyn Adams, Toufiek Samaai, MG van der Bank, Maya C. Pfaff, JB Mann-Lang, Bruce Q. Mann, and T-C Livingstone
- Subjects
Geography ,Ecology ,fungi ,Fishing ,%22">Fish ,Marine protected area ,Aquatic Science ,Ecology, Evolution, Behavior and Systematics ,Invertebrate - Abstract
We reviewed 140 papers to assess the ecological effectiveness of South Africa’s marine protected areas (MPAs). Evidence was assessed for coverage and representivity, protection of important biodive...
- Published
- 2021
- Full Text
- View/download PDF
9. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
- Author
-
S. Moses Dennison, Kun Luo, Alexis A. Bitzer, Yuanzhang Li, William Washington, Rajeshwer S. Sankhala, Misook Choe, Viseth Ngauy, Alish Giri, Xiaoyan Zou, M. Gordon Joyce, Georgia D. Tomaras, Merricka C. Livingstone, Sheetij Dutta, and Adrian H. Batchelor
- Subjects
0301 basic medicine ,medicine.drug_class ,Science ,030231 tropical medicine ,Immunology ,Primary Cell Culture ,Protozoan Proteins ,Antibodies, Protozoan ,Diseases ,Monoclonal antibody ,Microbiology ,Epitope ,Article ,law.invention ,Cell Line ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Antigen ,In vivo ,law ,Malaria Vaccines ,parasitic diseases ,medicine ,Animals ,Humans ,Malaria, Falciparum ,Multidisciplinary ,biology ,Molecular medicine ,Antibodies, Monoclonal ,Plasmodium falciparum ,biology.organism_classification ,Virology ,In vitro ,Circumsporozoite protein ,Mice, Inbred C57BL ,030104 developmental biology ,Sporozoites ,Recombinant DNA ,Hepatocytes ,Medicine ,Female ,Structural biology - Abstract
Plasmodium falciparum malaria contributes to a significant global disease burden. Circumsporozoite protein (CSP), the most abundant sporozoite stage antigen, is a prime vaccine candidate. Inhibitory monoclonal antibodies (mAbs) against CSP map to either a short junctional sequence or the central (NPNA)n repeat region. We compared in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a recombinant CSP vaccine RTS,S/AS01 (mAbs 317 and 311); an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria (mAbs 580 and 663). RTS,S mAb 317 that specifically binds the (NPNA)n epitope, had the highest affinity and it elicited the best sterile protection in mice. The most potent inhibitor of sporozoite invasion in vitro was mAb CIS43 which shows dual-specific binding to the junctional sequence and (NPNA)n. In vivo mouse protection was associated with the mAb reactivity to the NANPx6 peptide, the in vitro inhibition of sporozoite invasion activity, and kinetic parameters measured using intact mAbs or their Fab fragments. Buried surface area between mAb and its target epitope was also associated with in vivo protection. Association and disconnects between in vitro and in vivo readouts has important implications for the design and down-selection of the next generation of CSP based interventions.
- Published
- 2021
10. Portable neuromodulation induces neuroplasticity to re-activate motor function recovery from brain injury: a high-density MEG case study
- Author
-
Pamela Tannouri, Pauline Martin, Fabio Bollinger, Debbie Greene, Natasha K J Campbell, Zack Frehlick, Yuri Danilov, Shaun D. Fickling, Ashley C. Livingstone, Ryan C.N. D'Arcy, Christopher J. Smith, Bimal Lakhani, Tori Etheridge, and Trevor Greene
- Subjects
Adult ,Male ,Canada ,030506 rehabilitation ,Traumatic brain injury ,medicine.medical_treatment ,Electric Stimulation Therapy ,Health Informatics ,Electroencephalography ,behavioral disciplines and activities ,Translingual neurostimulation (TLNS) ,lcsh:RC321-571 ,Functional connectivity ,03 medical and health sciences ,0302 clinical medicine ,Brain Injuries, Traumatic ,Neuroplasticity ,Humans ,Medicine ,Magnetoencephalography (MEG) ,Electroencephalography (EEG) ,Traumatic brain injury (TBI) ,Neurostimulation ,Motor function ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Physical Therapy Modalities ,Neuronal Plasticity ,Rehabilitation ,medicine.diagnostic_test ,Brain vital signs ,business.industry ,Research ,Brain ,Magnetoencephalography ,Recovery of Function ,medicine.disease ,Magnetic Resonance Imaging ,Neuromodulation (medicine) ,Functional imaging ,Portable neuromodulation stimulator (PoNS) ,nervous system ,0305 other medical science ,business ,Functional magnetic resonance imaging ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Background In a recent high-profile case study, we used functional magnetic resonance imaging (fMRI) to monitor improvements in motor function related to neuroplasticity following rehabilitation for severe traumatic brain injury (TBI). The findings demonstrated that motor function improvements can occur years beyond current established limits. The current study extends the functional imaging investigation to characterize neuromodulation effects on neuroplasticity to further push the limits. Methods Canadian Soldier Captain (retired) Trevor Greene (TG) survived a severe open-TBI when attacked with an axe during a 2006 combat tour in Afghanistan. TG has since continued intensive daily rehabilitation to recover motor function, experiencing an extended plateau using conventional physical therapy. To overcome this plateau, we paired translingual neurostimulation (TLNS) with the continuing rehabilitation program. Results Combining TLNS with rehabilitation resulted in demonstrable clinical improvements along with corresponding changes in movement evoked electro-encephalography (EEG) activity. High-density magneto-encephalography (MEG) characterized cortical activation changes in corresponding beta frequency range (27 Hz). MEG activation changes corresponded with reduced interhemispheric inhibition in the post-central gyri regions together with increased right superior/middle frontal activation suggesting large scale network level changes. Conclusions The findings provide valuable insight into the potential importance of non-invasive neuromodulation to enhance neuroplasticity mechanisms for recovery beyond the perceived limits of rehabilitation.
- Published
- 2020
11. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
- Author
-
Marco Vitolo, Vincenzo L. Malavasi, Marco Proietti, Igor Diemberger, Laurent Fauchier, Francisco Marin, Michael Nabauer, Tatjana S. Potpara, Gheorghe-Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo Pietro Maggioni, Deirdre A. Lane, Gregory Y.H. Lip, Giuseppe Boriani, G. Boriani, G.Y.H. Lip, L. Tavazzi, A.P. Maggioni, G-A. Dan, T. Potpara, M. Nabauer, F. Marin, Z. Kalarus, L. Fauchier, A. Goda, G. Mairesse, T. Shalganov, L. Antoniades, M. Taborsky, S. Riahi, P. Muda, I. García Bolao, O. Piot, K. Etsadashvili, M. Haim, A. Azhari, J. Najafian, M. Santini, E. Mirrakhimov, K. Kulzida, A. Erglis, L. Poposka, M.R. Burg, H. Crijns, Ö. Erküner, D. Atar, R. Lenarczyk, M. Martins Oliveira, D. Shah, E. Serdechnaya, E. Diker, E. Zëra, U. Ekmekçiu, V. Paparisto, M. Tase, H. Gjergo, J. Dragoti, M. Ciutea, N. Ahadi, Z. el Husseini, M. Raepers, J. Leroy, P. Haushan, A. Jourdan, C. Lepiece, L. Desteghe, J. Vijgen, P. Koopman, G. Van Genechten, H. Heidbuchel, T. Boussy, M. De Coninck, H. Van Eeckhoutte, N. Bouckaert, A. Friart, J. Boreux, C. Arend, P. Evrard, L. Stefan, E. Hoffer, J. Herzet, M. Massoz, C. Celentano, M. Sprynger, L. Pierard, P. Melon, B. Van Hauwaert, C. Kuppens, D. Faes, D. Van Lier, A. Van Dorpe, A. Gerardy, O. Deceuninck, O. Xhaet, F. Dormal, E. Ballant, D. Blommaert, D. Yakova, M. Hristov, T. Yncheva, N. Stancheva, S. Tisheva, M. Tokmakova, F. Nikolov, D. Gencheva, B. Kunev, M. Stoyanov, D. Marchov, V. Gelev, V. Traykov, A. Kisheva, H. Tsvyatkov, R. Shtereva, S. Bakalska-Georgieva, S. Slavcheva, Y. Yotov, M. Kubíčková, A. Marni Joensen, A. Gammelmark, L. Hvilsted Rasmussen, P. Dinesen, S. Krogh Venø, B. Sorensen, A. Korsgaard, K. Andersen, C. Fragtrup Hellum, A. Svenningsen, O. Nyvad, P. Wiggers, O. May, A. Aarup, B. Graversen, L. Jensen, M. Andersen, M. Svejgaard, S. Vester, S. Hansen, V. Lynggaard, M. Ciudad, R. Vettus, A. Maestre, S. Castaño, S. Cheggour, J. Poulard, V. Mouquet, S. Leparrée, J. Bouet, J. Taieb, A. Doucy, H. Duquenne, A. Furber, J. Dupuis, J. Rautureau, M. Font, P. Damiano, M. Lacrimini, J. Abalea, S. Boismal, T. Menez, J. Mansourati, G. Range, H. Gorka, C. Laure, C. Vassalière, N. Elbaz, N. Lellouche, K. Djouadi, F. Roubille, D. Dietz, J. Davy, M. Granier, P. Winum, C. Leperchois-Jacquey, H. Kassim, E. Marijon, J. Le Heuzey, J. Fedida, C. Maupain, C. Himbert, E. Gandjbakhch, F. Hidden-Lucet, G. Duthoit, N. Badenco, T. Chastre, X. Waintraub, M. Oudihat, J. Lacoste, C. Stephan, H. Bader, N. Delarche, L. Giry, D. Arnaud, C. Lopez, F. Boury, I. Brunello, M. Lefèvre, R. Mingam, M. Haissaguerre, M. Le Bidan, D. Pavin, V. Le Moal, C. Leclercq, T. Beitar, I. Martel, A. Schmid, N. Sadki, C. Romeyer-Bouchard, A. Da Costa, I. Arnault, M. Boyer, C. Piat, N. Lozance, S. Nastevska, A. Doneva, B. Fortomaroska Milevska, B. Sheshoski, K. Petroska, N. Taneska, N. Bakrecheski, K. Lazarovska, S. Jovevska, V. Ristovski, A. Antovski, E. Lazarova, I. Kotlar, J. Taleski, S. Kedev, N. Zlatanovik, S. Jordanova, T. Bajraktarova Proseva, S. Doncovska, D. Maisuradze, A. Esakia, E. Sagirashvili, K. Lartsuliani, N. Natelashvili, N. Gumberidze, R. Gvenetadze, N. Gotonelia, N. Kuridze, G. Papiashvili, I. Menabde, S. Glöggler, A. Napp, C. Lebherz, H. Romero, K. Schmitz, M. Berger, M. Zink, S. Köster, J. Sachse, E. Vonderhagen, G. Soiron, K. Mischke, R. Reith, M. Schneider, W. Rieker, D. Boscher, A. Taschareck, A. Beer, D. Oster, O. Ritter, J. Adamczewski, S. Walter, A. Frommhold, E. Luckner, J. Richter, M. Schellner, S. Landgraf, S. Bartholome, R. Naumann, J. Schoeler, D. Westermeier, F. William, K. Wilhelm, M. Maerkl, R. Oekinghaus, M. Denart, M. Kriete, U. Tebbe, T. Scheibner, M. Gruber, A. Gerlach, C. Beckendorf, L. Anneken, M. Arnold, S. Lengerer, Z. Bal, C. Uecker, H. Förtsch, S. Fechner, V. Mages, E. Martens, H. Methe, T. Schmidt, B. Schaeffer, B. Hoffmann, J. Moser, K. Heitmann, S. Willems, C. Klaus, I. Lange, M. Durak, E. Esen, F. Mibach, H. Mibach, A. Utech, M. Gabelmann, R. Stumm, V. Ländle, C. Gartner, C. Goerg, N. Kaul, S. Messer, D. Burkhardt, C. Sander, R. Orthen, S. Kaes, A. Baumer, F. Dodos, A. Barth, G. Schaeffer, J. Gaertner, J. Winkler, A. Fahrig, J. Aring, I. Wenzel, S. Steiner, A. Kliesch, E. Kratz, K. Winter, P. Schneider, A. Haag, I. Mutscher, R. Bosch, J. Taggeselle, S. Meixner, A. Schnabel, A. Shamalla, H. Hötz, A. Korinth, C. Rheinert, G. Mehltretter, B. Schön, N. Schön, A. Starflinger, E. Englmann, G. Baytok, T. Laschinger, G. Ritscher, A. Gerth, D. Dechering, L. Eckardt, M. Kuhlmann, N. Proskynitopoulos, J. Brunn, K. Foth, C. Axthelm, H. Hohensee, K. Eberhard, S. Turbanisch, N. Hassler, A. Koestler, G. Stenzel, D. Kschiwan, M. Schwefer, S. Neiner, S. Hettwer, M. Haeussler-Schuchardt, R. Degenhardt, S. Sennhenn, M. Brendel, A. Stoehr, W. Widjaja, S. Loehndorf, A. Logemann, J. Hoskamp, J. Grundt, M. Block, R. Ulrych, A. Reithmeier, V. Panagopoulos, C. Martignani, D. Bernucci, E. Fantecchi, I. Diemberger, M. Ziacchi, M. Biffi, P. Cimaglia, J. Frisoni, I. Giannini, S. Boni, S. Fumagalli, S. Pupo, A. Di Chiara, P. Mirone, F. Pesce, C. Zoccali, V.L. Malavasi, A. Mussagaliyeva, B. Ahyt, Z. Salihova, K. Koshum-Bayeva, A. Kerimkulova, A. Bairamukova, B. Lurina, R. Zuzans, S. Jegere, I. Mintale, K. Kupics, K. Jubele, O. Kalejs, K. Vanhear, M. Burg, M. Cachia, E. Abela, S. Warwicker, T. Tabone, R. Xuereb, D. Asanovic, D. Drakalovic, M. Vukmirovic, N. Pavlovic, L. Music, N. Bulatovic, A. Boskovic, H. Uiterwaal, N. Bijsterveld, J. De Groot, J. Neefs, N. van den Berg, F. Piersma, A. Wilde, V. Hagens, J. Van Es, J. Van Opstal, B. Van Rennes, H. Verheij, W. Breukers, G. Tjeerdsma, R. Nijmeijer, D. Wegink, R. Binnema, S. Said, S. Philippens, W. van Doorn, T. Szili-Torok, R. Bhagwandien, P. Janse, A. Muskens, M. van Eck, R. Gevers, N. van der Ven, A. Duygun, B. Rahel, J. Meeder, A. Vold, C. Holst Hansen, I. Engset, B. Dyduch-Fejklowicz, E. Koba, M. Cichocka, A. Sokal, A. Kubicius, E. Pruchniewicz, A. Kowalik-Sztylc, W. Czapla, I. Mróz, M. Kozlowski, T. Pawlowski, M. Tendera, A. Winiarska-Filipek, A. Fidyk, A. Slowikowski, M. Haberka, M. Lachor-Broda, M. Biedron, Z. Gasior, M. Kołodziej, M. Janion, I. Gorczyca-Michta, B. Wozakowska-Kaplon, M. Stasiak, P. Jakubowski, T. Ciurus, J. Drozdz, M. Simiera, P. Zajac, T. Wcislo, P. Zycinski, J. Kasprzak, A. Olejnik, E. Harc-Dyl, J. Miarka, M. Pasieka, M. Ziemińska-Łuć, W. Bujak, A. Śliwiński, A. Grech, J. Morka, K. Petrykowska, M. Prasał, G. Hordyński, P. Feusette, P. Lipski, A. Wester, W. Streb, J. Romanek, P. Woźniak, M. Chlebuś, P. Szafarz, W. Stanik, M. Zakrzewski, J. Kaźmierczak, A. Przybylska, E. Skorek, H. Błaszczyk, M. Stępień, S. Szabowski, W. Krysiak, M. Szymańska, J. Karasiński, J. Blicharz, M. Skura, K. Hałas, L. Michalczyk, Z. Orski, K. Krzyżanowski, A. Skrobowski, L. Zieliński, M. Tomaszewska-Kiecana, M. Dłużniewski, M. Kiliszek, M. Peller, M. Budnik, P. Balsam, G. Opolski, A. Tymińska, K. Ozierański, A. Wancerz, A. Borowiec, E. Majos, R. Dabrowski, H. Szwed, A. Musialik-Lydka, A. Leopold-Jadczyk, E. Jedrzejczyk-Patej, M. Koziel, M. Mazurek, K. Krzemien-Wolska, P. Starosta, E. Nowalany-Kozielska, A. Orzechowska, M. Szpot, M. Staszel, S. Almeida, H. Pereira, L. Brandão Alves, R. Miranda, L. Ribeiro, F. Costa, F. Morgado, P. Carmo, P. Galvao Santos, R. Bernardo, P. Adragão, G. Ferreira da Silva, M. Peres, M. Alves, M. Leal, A. Cordeiro, P. Magalhães, P. Fontes, S. Leão, A. Delgado, A. Costa, B. Marmelo, B. Rodrigues, D. Moreira, J. Santos, L. Santos, A. Terchet, D. Darabantiu, S. Mercea, V. Turcin Halka, A. Pop Moldovan, A. Gabor, B. Doka, G. Catanescu, H. Rus, L. Oboroceanu, E. Bobescu, R. Popescu, A. Dan, A. Buzea, I. Daha, G. Dan, I. Neuhoff, M. Baluta, R. Ploesteanu, N. Dumitrache, M. Vintila, A. Daraban, C. Japie, E. Badila, H. Tewelde, M. Hostiuc, S. Frunza, E. Tintea, D. Bartos, A. Ciobanu, I. Popescu, N. Toma, C. Gherghinescu, D. Cretu, N. Patrascu, C. Stoicescu, C. Udroiu, G. Bicescu, V. Vintila, D. Vinereanu, M. Cinteza, R. Rimbas, M. Grecu, A. Cozma, F. Boros, M. Ille, O. Tica, R. Tor, A. Corina, A. Jeewooth, B. Maria, C. Georgiana, C. Natalia, D. Alin, D. Dinu-Andrei, M. Livia, R. Daniela, R. Larisa, S. Umaar, T. Tamara, M. Ioachim Popescu, D. Nistor, I. Sus, O. Coborosanu, N. Alina-Ramona, R. Dan, L. Petrescu, G. Ionescu, C. Vacarescu, E. Goanta, M. Mangea, A. Ionac, C. Mornos, D. Cozma, S. Pescariu, E. Solodovnicova, I. Soldatova, J. Shutova, L. Tjuleneva, T. Zubova, V. Uskov, D. Obukhov, G. Rusanova, N. Isakova, S. Odinsova, T. Arhipova, E. Kazakevich, O. Zavyalova, T. Novikova, I. Riabaia, S. Zhigalov, E. Drozdova, I. Luchkina, Y. Monogarova, D. Hegya, L. Rodionova, V. Nevzorova, O. Lusanova, A. Arandjelovic, D. Toncev, L. Vukmirovic, M. Radisavljevic, M. Milanov, N. Sekularac, M. Zdravkovic, S. Hinic, S. Dimkovic, T. Acimovic, J. Saric, S. Radovanovic, A. Kocijancic, B. Obrenovic-Kircanski, D. Kalimanovska Ostric, D. Simic, I. Jovanovic, I. Petrovic, M. Polovina, M. Vukicevic, M. Tomasevic, N. Mujovic, N. Radivojevic, O. Petrovic, S. Aleksandric, V. Kovacevic, Z. Mijatovic, B. Ivanovic, M. Tesic, A. Ristic, B. Vujisic-Tesic, M. Nedeljkovic, A. Karadzic, A. Uscumlic, M. Prodanovic, M. Zlatar, M. Asanin, B. Bisenic, V. Vasic, Z. Popovic, D. Djikic, M. Sipic, V. Peric, B. Dejanovic, N. Milosevic, S. Backovic, A. Stevanovic, A. Andric, B. Pencic, M. Pavlovic-Kleut, V. Celic, M. Pavlovic, M. Petrovic, M. Vuleta, N. Petrovic, S. Simovic, Z. Savovic, S. Milanov, G. Davidovic, V. Iric-Cupic, D. Djordjevic, M. Damjanovic, S. Zdravkovic, V. Topic, D. Stanojevic, M. Randjelovic, R. Jankovic-Tomasevic, V. Atanaskovic, S. Antic, D. Simonovic, M. Stojanovic, S. Stojanovic, V. Mitic, V. Ilic, D. Petrovic, M. Deljanin Ilic, S. Ilic, V. Stoickov, S. Markovic, A. Mijatovic, D. Tanasic, G. Radakovic, J. Peranovic, N. Panic-Jelic, O. Vujadinovic, P. Pajic, S. Bekic, S. Kovacevic, A. García Fernandez, A. Perez Cabeza, M. Anguita, L. Tercedor Sanchez, E. Mau, J. Loayssa, M. Ayarra, M. Carpintero, I. Roldán Rabadan, M. Gil Ortega, A. Tello Montoliu, E. Orenes Piñero, S. Manzano Fernández, F. Marín, A. Romero Aniorte, A. Veliz Martínez, M. Quintana Giner, G. Ballesteros, M. Palacio, O. Alcalde, I. García-Bolao, V. Bertomeu Gonzalez, F. Otero-Raviña, J. García Seara, J. Gonzalez Juanatey, N. Dayal, P. Maziarski, P. Gentil-Baron, M. Koç, E. Onrat, I.E. Dural, K. Yilmaz, B. Özin, S. Tan Kurklu, Y. Atmaca, U. Canpolat, L. Tokgozoglu, A.K. Dolu, B. Demirtas, D. Sahin, O. Ozcan Celebi, G. Gagirci, U.O. Turk, H. Ari, N. Polat, N. Toprak, M. Sucu, O. Akin Serdar, A. Taha Alper, A. Kepez, Y. Yuksel, A. Uzunselvi, S. Yuksel, M. Sahin, O. Kayapinar, T. Ozcan, H. Kaya, M.B. Yilmaz, M. Kutlu, M. Demir, C. Gibbs, S. Kaminskiene, M. Bryce, A. Skinner, G. Belcher, J. Hunt, L. Stancombe, B. Holbrook, C. Peters, S. Tettersell, A. Shantsila, D. Lane, K. Senoo, M. Proietti, K. Russell, P. Domingos, S. Hussain, J. Partridge, R. Haynes, S. Bahadur, R. Brown, S. McMahon, J. McDonald, K. Balachandran, R. Singh, S. Garg, H. Desai, K. Davies, W. Goddard, G. Galasko, I. Rahman, Y. Chua, O. Payne, S. Preston, O. Brennan, L. Pedley, C. Whiteside, C. Dickinson, J. Brown, K. Jones, L. Benham, R. Brady, L. Buchanan, A. Ashton, H. Crowther, H. Fairlamb, S. Thornthwaite, C. Relph, A. McSkeane, U. Poultney, N. Kelsall, P. Rice, T. Wilson, M. Wrigley, R. Kaba, T. Patel, E. Young, J. Law, C. Runnett, H. Thomas, H. McKie, J. Fuller, S. Pick, A. Sharp, A. Hunt, K. Thorpe, C. Hardman, E. Cusack, L. Adams, M. Hough, S. Keenan, A. Bowring, J. Watts, J. Zaman, K. Goffin, H. Nutt, Y. Beerachee, J. Featherstone, C. Mills, J. Pearson, L. Stephenson, S. Grant, A. Wilson, C. Hawksworth, I. Alam, M. Robinson, S. Ryan, R. Egdell, E. Gibson, M. Holland, D. Leonard, B. Mishra, S. Ahmad, H. Randall, J. Hill, L. Reid, M. George, S. McKinley, L. Brockway, W. Milligan, J. Sobolewska, J. Muir, L. Tuckis, L. Winstanley, P. Jacob, S. Kaye, L. Morby, A. Jan, T. Sewell, C. Boos, B. Wadams, C. Cope, P. Jefferey, N. Andrews, A. Getty, A. Suttling, C. Turner, K. Hudson, R. Austin, S. Howe, R. Iqbal, N. Gandhi, K. Brophy, P. Mirza, E. Willard, S. Collins, N. Ndlovu, E. Subkovas, V. Karthikeyan, L. Waggett, A. Wood, A. Bolger, J. Stockport, L. Evans, E. Harman, J. Starling, L. Williams, V. Saul, M. Sinha, L. Bell, S. Tudgay, S. Kemp, L. Frost, T. Ingram, A. Loughlin, C. Adams, M. Adams, F. Hurford, C. Owen, C. Miller, D. Donaldson, H. Tivenan, H. Button, A. Nasser, O. Jhagra, B. Stidolph, C. Brown, C. Livingstone, M. Duffy, P. Madgwick, P. Roberts, E. Greenwood, L. Fletcher, M. Beveridge, S. Earles, D. McKenzie, D. Beacock, M. Dayer, M. Seddon, D. Greenwell, F. Luxton, F. Venn, H. Mills, J. Rewbury, K. James, K. Roberts, L. Tonks, D. Felmeden, W. Taggu, A. Summerhayes, D. Hughes, J. Sutton, L. Felmeden, M. Khan, E. Walker, L. Norris, L. O'Donohoe, A. Mozid, H. Dymond, H. Lloyd-Jones, G. Saunders, D. Simmons, D. Coles, D. Cotterill, S. Beech, S. Kidd, B. Wrigley, S. Petkar, A. Smallwood, R. Jones, E. Radford, S. Milgate, S. Metherell, V. Cottam, C. Buckley, A. Broadley, D. Wood, J. Allison, K. Rennie, L. Balian, L. Howard, L. Pippard, S. Board, and T. Pitt-Kerby
- Subjects
Male ,AF registry ,Atrial fibrillation ,Biomarkers ,Death ,Major adverse cardiovascular events ,outcomes ,Troponins ,Troponin ,Risk Factors ,Atrial Fibrillation ,Internal Medicine ,Humans ,Female ,Prospective Studies ,Registries ,Aged - Abstract
BACKGROUND: Cardiac troponins (cTn) have been reported to be predictors for adverse outcomes in atrial fibrillation (AF), patients, but their actual use is still unclear.AIM: To assess the factors associated with cTn testing in routine practice and evaluate the association with outcomes.METHODS: Patients enrolled in the ESC-EHRA EORP-AF General Long-Term Registry were stratified into 3 groups according to cTn levels as (i) cTn not tested, (ii) cTn in range (≤99th percentile), (iii) cTn elevated (>99th percentile). The composite outcome of any thromboembolism /any acute coronary syndrome/cardiovascular (CV) death, defined as Major Adverse Cardiovascular Events (MACE) and all-cause death were the main endpoints.RESULTS: Among 10 445 AF patients (median age 71 years, 40.3% females) cTn were tested in 2834 (27.1%). cTn was elevated in 904/2834 (31.9%) and in-range in 1930/2834 (68.1%) patients. Female sex, in-hospital enrollment, first-detected AF, CV risk factors, history of coronary artery disease, and atypical AF symptoms were independently associated with cTn testing. Elevated cTn were independently associated with a higher risk for MACE (Model 1, hazard ratio [HR] 1.74, 95% confidence interval [CI] 1.40-2.16, Model 2, HR 1.62, 95% CI 1.28-2.05; Model 3 HR 1.76, 95% CI 1.37-2.26) and all-cause death (Model 1, HR 1.45, 95% CI 1.21-1.74; Model 2, HR 1.36, 95% CI 1.12-1.66; Model 3, HR 1.38, 95% CI 1.12-1.71).CONCLUSIONS: Elevated cTn levels were associated with an increased risk of all-cause mortality and adverse CV events. Clinical factors that might enhance the need to rule out CAD were associated with cTn testing.
- Published
- 2022
- Full Text
- View/download PDF
12. Diversion of Attention Leads to Conflict between Concurrently Attended Stimuli, Not Delayed Orienting to the Object of Interest
- Author
-
John J. McDonald, Ashley C. Livingstone, Andrea N. Smit, and Jennifer-Ashley Hoffmeister
- Subjects
genetic structures ,Cognitive Neuroscience ,media_common.quotation_subject ,05 social sciences ,Object (grammar) ,Stimulus (physiology) ,behavioral disciplines and activities ,050105 experimental psychology ,03 medical and health sciences ,0302 clinical medicine ,Perception ,Distraction ,Selection (linguistics) ,Reaction Time ,Visual Perception ,Humans ,0501 psychology and cognitive sciences ,Psychology ,Evoked Potentials ,030217 neurology & neurosurgery ,Photic Stimulation ,media_common ,Cognitive psychology - Abstract
The control processes that guide attention to a visual-search target can result in the selection of an irrelevant object with similar features (a distractor). Once attention is captured by such a distractor, search for a subsequent target is momentarily impaired if the two stimuli appear at different locations. The textbook explanation for this impairment is based on the notion of an indivisible focus of attention that moves to the distractor, illuminates a nontarget that subsequently appears at that location, and then moves to the target once the nontarget is rejected. Here, we show that such delayed orienting to the target does not underlie the behavioral cost of distraction. Observers identified a color-defined target appearing within the second of two stimulus arrays. The first array contained irrelevant items, including one that shared the target's color. ERPs were examined to test two predictions stemming from the textbook serial-orienting hypothesis. Namely, when the target and distractor appear at different locations, (1) the target should elicit delayed selection activity relative to same-location trials, and (2) the nontarget search item appearing at the distractor location should elicit selection activity that precedes selection activity tied to the target. Here, the posterior contralateral N2 component was used to track selection of each of these search-array items and the previous distractor. The results supported neither prediction above, thereby disconfirming the serial-orienting hypothesis. Overall, the results show that the behavioral costs of distraction are caused by perceptual and postperceptual competition between concurrently attended target and nontarget stimuli.
- Published
- 2021
13. Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform
- Author
-
Merricka C. Livingstone, Sheetij Dutta, Andrew J. Schrader, Kimberly Soto, Monica L. Martin, Zoltan Beck, Xiaoyan Zou, Mark D Langowski, Farhat Khan, Sri Hadiwidjojo, Christopher J. Genito, Alexis A. Bitzer, Gary R. Matyas, and Adrian H. Batchelor
- Subjects
Models, Molecular ,Antigenicity ,animal structures ,Recombinant Fusion Proteins ,Plasmodium falciparum ,malaria ,Protozoan Proteins ,Antibodies, Protozoan ,immunogenicity ,Protein Engineering ,complex mixtures ,Epitope ,Mice ,Immunology and Inflammation ,Immunogenicity, Vaccine ,CSP ,Malaria Vaccines ,parasitic diseases ,Animals ,Humans ,Avidity ,Malaria, Falciparum ,Multidisciplinary ,biology ,Malaria vaccine ,Immunogenicity ,fungi ,Antibody titer ,Biological Sciences ,vaccines ,biology.organism_classification ,Macaca mulatta ,Virology ,Mice, Inbred C57BL ,Tobacco Mosaic Virus ,Circumsporozoite protein ,HEK293 Cells ,antigenicity - Abstract
Significance RTS,S/AS01 is a circumsporozoite protein (CSP)-based malaria vaccine that confers partial protection against malaria in endemic areas. Recent reports have elucidated structures of monoclonal antibodies that bind to the central (NPNA) repeat region of CSP and that inhibit parasite invasion. Antigen configuration and copy number of CSP repeats displayed on a tobacco mosaic virus (TMV) particle platform were studied. A TMV vaccine containing CSP repeats displayed as a loop induced 10× better antibody titer than a nearly full-length CSP in mice. In rhesus model, this translated to a 5× improvement in titer. Rhesus antibodies potently inhibited parasite invasion up to 11 mo after vaccination. An optimized epitope-focused, repeat-only CSP vaccine may be sufficient or better than the existing CSP vaccines., Plasmodium falciparum vaccine RTS,S/AS01 is based on the major NPNA repeat and the C-terminal region of the circumsporozoite protein (CSP). RTS,S-induced NPNA-specific antibody titer and avidity have been associated with high-level protection in naïve subjects, but efficacy and longevity in target populations is relatively low. In an effort to improve upon RTS,S, a minimal repeat-only, epitope-focused, protective, malaria vaccine was designed. Repeat antigen copy number and flexibility was optimized using the tobacco mosaic virus (TMV) display platform. Comparing antigenicity of TMV displaying 3 to 20 copies of NPNA revealed that low copy number can reduce the abundance of low-affinity monoclonal antibody (mAb) epitopes while retaining high-affinity mAb epitopes. TMV presentation improved titer and avidity of repeat-specific Abs compared to a nearly full-length protein vaccine (FL-CSP). NPNAx5 antigen displayed as a loop on the TMV particle was found to be most optimal and its efficacy could be further augmented by combination with a human-use adjuvant ALFQ that contains immune-stimulators. These data were confirmed in rhesus macaques where a low dose of TMV-NPNAx5 elicited Abs that persisted at functional levels for up to 11 mo. We show here a complex association between NPNA copy number, flexibility, antigenicity, immunogenicity, and efficacy of CSP-based vaccines. We hypothesize that designing minimal epitope CSP vaccines could confer better and more durable protection against malaria. Preclinical data presented here supports the evaluation of TMV-NPNAx5/ALFQ in human trials.
- Published
- 2020
- Full Text
- View/download PDF
14. Serum miR‐182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats
- Author
-
Merricka C. Livingstone, Natalie M. Johnson, John D. Groopman, Bill D. Roebuck, and Thomas W. Kensler
- Subjects
0301 basic medicine ,Chemoprotective agent ,Cancer Research ,Aflatoxin ,Carcinoma, Hepatocellular ,Carcinogenesis ,Biology ,Article ,Transcriptome ,03 medical and health sciences ,0302 clinical medicine ,Aflatoxins ,Downregulation and upregulation ,microRNA ,Biomarkers, Tumor ,medicine ,Animals ,Humans ,Molecular Biology ,Predictive biomarker ,Liver Neoplasms ,Translation (biology) ,medicine.disease ,Rats ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,030104 developmental biology ,Liver ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Cancer research - Abstract
Exploration of animal models leads to discoveries that can reveal candidate biomarkers for translation to human populations. Herein, a model of hepatocarcinogenesis and protection was used in which rats treated with aflatoxin (AFB1 ) daily for 28 days (200 µg/kg BW) developed tumors compared with rats completely protected from tumors by concurrent administration of the chemoprotective agent, 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im). Differential expression of miRNAs in tumors (AFB1 ) and nontumor (AFB1 + CDDO-Im) bearing livers and their levels in sera over the life-course of the animals was determined. miRNA transcriptome analysis identified 17 miRNAs significantly upregulated at greater than five-fold in the tumors. The ten most dysregulated miRNAs judged by fold-change and biological significance were selected for further study, including liver-specific miR-122-5p. Validation of sequencing results by real-time PCR confirmed the upregulation of the majority of these miRNAs in tumors, including miR-182, as well as miR-224-5p as the most dysregulated of these miRNAs (over 400-fold). The longitudinal analysis of levels of miR-182 in sera demonstrated significant and persistent increases (5.13-fold; 95% CI: 4.59-5.70). The increase in miR-182 was detected months before any clinical symptoms were present in the animals. By the terminal time point of the study, in addition to elevated levels of serum miR-182, serum miR-122-5p was also found to be increased (>1.5-fold) in animals that developed hepatocarcinomas. Thus, using the data from an unbiased discovery approach of the tissue findings, serum miR-182 was found to track across the complex, multistage process of hepatocarcinogenesis opening an opportunity for translation to human populations.
- Published
- 2019
- Full Text
- View/download PDF
15. Impact of Covid-19 Social-distancing on Sleep Timing and Duration During a University Semester
- Author
-
Stephanie R. U., Ashley C. Livingstone, Ralph E. Mistlberger, Myriam Juda, and Andrea N. Smit
- Subjects
Male ,Viral Diseases ,Time Factors ,Research Facilities ,Physiology ,Social Sciences ,Information Centers ,Time Measurement ,Medical Conditions ,Sociology ,Sleep debt ,Surveys and Questionnaires ,Medicine and Health Sciences ,Morning ,Measurement ,Schools ,Multidisciplinary ,Geography ,Archives ,Social distance ,Circadian Rhythm ,Circadian Rhythms ,Infectious Diseases ,Engineering and Technology ,Medicine ,Female ,Sleep (system call) ,Psychology ,Research Article ,Clinical psychology ,Adult ,Evening ,Universities ,Science ,Physical Distancing ,education ,Research and Analysis Methods ,Human Geography ,Affect (psychology) ,Education ,Young Adult ,Humans ,Adults ,SARS-CoV-2 ,COVID-19 ,Biology and Life Sciences ,Chronotype ,Covid 19 ,Mental health ,Young Adults ,Cross-Sectional Studies ,Age Groups ,People and Places ,Earth Sciences ,Human Mobility ,Population Groupings ,Sleep ,Physiological Processes ,Chronobiology - Abstract
Social-distancing directives to contain community transmission of the COVID-19 virus can be expected to affect sleep timing, duration or quality. Remote work or school may increase time available for sleep, with benefits for immune function and mental health, particularly in those individuals who obtain less sleep than age-adjusted recommendations. Young adults are thought to regularly carry significant sleep debt related in part to misalignment between endogenous circadian clock time and social time. We examined the impact of social-distancing measures on sleep in young adults by comparing sleep self-studies submitted by students enrolled in a university course during the 2020 summer session (entirely remote instruction, N = 80) with self-studies submitted by students enrolled in the same course during previous summer semesters (on-campus instruction, N = 452; cross-sectional study design). Self-studies included 2–8 week sleep diaries, two chronotype questionnaires, written reports, and sleep tracker (Fitbit) data from a subsample. Students in the 2020 remote instruction semester slept later, less efficiently, less at night and more in the day, but did not sleep more overall despite online, asynchronous classes and ~44% fewer work days compared to students in previous summers. Subjectively, the net impact on sleep was judged as positive or negative in equal numbers of students, with students identifying as evening types significantly more likely to report a positive impact, and morning types a negative impact. Several features of the data suggest that the average amount of sleep reported by students in this summer course, historically and during the 2020 remote school semester, represents a homeostatic balance, rather than a chronic deficit. Regardless of the interpretation, the results provide additional evidence that social-distancing measures affect sleep in heterogeneous ways.
- Published
- 2021
16. Profound changes in miRNA expression during cancer initiation by aflatoxin B1and their abrogation by the chemopreventive triterpenoid CDDO-Im
- Author
-
Bill D. Roebuck, Thomas W. Kensler, Merricka C. Livingstone, Natalie M. Johnson, and John D. Groopman
- Subjects
0301 basic medicine ,Genetics ,Cancer Research ,Aflatoxin ,Period (gene) ,Cancer ,Biology ,medicine.disease ,medicine.disease_cause ,03 medical and health sciences ,030104 developmental biology ,Downregulation and upregulation ,Hepatocellular carcinoma ,microRNA ,medicine ,Cancer research ,Epigenetics ,Carcinogenesis ,Molecular Biology - Abstract
Aflatoxin B1 (AFB1) is a potent human and animal hepatocarcinogen. To investigate the effects of aflatoxin on miRNA expression during the initiation phase of carcinogenesis, next-generation sequencing was used to analyze liver tissues from F344 rats exposed to 200 µg/kg per day AFB1 for 4 weeks. A panel of miRNAs was identified that was upregulated with AFB1 treatment compared to controls: rno-miR-434-3p, rno-miR-411-5p, rno-miR-221-3p, rno-miR-127-3p, rno-miR-205, rno-miR-429, rno-miR-34a-5p, rno-miR-181c-3p, rno-miR-200b-3p, and rno-miR-541-5p. Analysis of rat livers exposed to AFB1 plus the chemopreventive triterpenoid CDDO-Im revealed a striking abrogation of this upregulation. These changes were validated by real-time PCR. We also explored the temporal variation in expression of the candidate miRNAs during the 4-week dosing period. Most of the candidate miRNAs were upregulated at week 1 and increased for the duration of AFB1 dosing over the 4-week period. Treatment with CDDO-Im ameliorated these effects at all time points. All candidate miRNAs were detectable in serum from aflatoxin treated animals; however, there was no significant difference in expression for 7 of the 11 miRNAs examined. Exposure to AFB1 upregulated miR-122-5p (5 fold), 34a-5p (13 fold), and 181c-3p (170 fold) compared with controls. The findings from this study give insight into epigenetic changes induced by aflatoxin taking place during the initial step of carcinogenesis. This article is protected by copyright. All rights reserved
- Published
- 2017
- Full Text
- View/download PDF
17. Human translingual neurostimulation alters resting brain activity in high-density EEG
- Author
-
Yuri Danilov, Shaun D. Fickling, Bimal Lakhani, Zack Frehlick, Jonathan M. Sackier, Ashley C. Livingstone, and Ryan C.N. D'Arcy
- Subjects
Adult ,Male ,030506 rehabilitation ,medicine.medical_specialty ,Neurology ,Brain activity and meditation ,medicine.medical_treatment ,Rest ,Central nervous system ,Health Informatics ,Stimulation ,Electroencephalography ,lcsh:RC321-571 ,03 medical and health sciences ,Tongue ,Neuroplasticity ,medicine ,Humans ,EEG ,Neurostimulation ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Neuronal Plasticity ,medicine.diagnostic_test ,business.industry ,Neuromodulation ,Research ,Rehabilitation ,Brain ,Neuromodulation (medicine) ,Electric Stimulation ,medicine.anatomical_structure ,Female ,0305 other medical science ,business ,Neuroscience ,Cranial nerve stimulation - Abstract
Background Despite growing evidence of a critical link between neuromodulation technologies and neuroplastic recovery, the underlying mechanisms of these technologies remain elusive. Objective To investigate physiological evidence of central nervous system (CNS) changes in humans during translingual neurostimulation (TLNS). Methods We used high-density electroencephalography (EEG) to measure changes in resting brain activity before, during, and after high frequency (HF) and low frequency (LF) TLNS. Results Wavelet power analysis around Cz and microstate analysis revealed significant changes after 20 min of stimulation compared to baseline. A secondary effect of exposure order was also identified, indicating a differential neuromodulatory influence of HF TLNS relative to LF TLNS on alpha and theta signal power. Conclusions These results further our understanding of the effects of TLNS on underlying resting brain activity, which in the long-term may contribute to the critical link between clinical effect and changes in brain activity.
- Published
- 2019
18. Circadian misalignment impairs ability to suppress visual distractions
- Author
-
John J. McDonald, Andrea N. Smit, Ralph E. Mistlberger, Mateusz Michalik, and Ashley C. Livingstone
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,genetic structures ,Adolescent ,Cognitive Neuroscience ,media_common.quotation_subject ,Experimental and Cognitive Psychology ,Audiology ,050105 experimental psychology ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Developmental Neuroscience ,Distraction ,Perception ,medicine ,Distracted driving ,Humans ,0501 psychology and cognitive sciences ,Attention ,Circadian rhythm ,10. No inequality ,Evoked Potentials ,Biological Psychiatry ,Morning ,media_common ,Endocrine and Autonomic Systems ,General Neuroscience ,05 social sciences ,Chronotype ,Circadian Rhythm ,Electrophysiology ,Neuropsychology and Physiological Psychology ,Neurology ,Visual Perception ,Female ,Psychology ,N2pc ,030217 neurology & neurosurgery ,Psychomotor Performance - Abstract
Evening-type individuals often perform poorly in the morning because of a mismatch between internal circadian time and external social time, a condition recognized as social jet lag. Performance impairments near the morning circadian (~24 hr) trough have been attributed to deficits in attention, but the nature of the impairment is unknown. Using electrophysiological indices of attentional selection (N2pc) and suppression (PD ), we show that evening-type individuals have a specific disability in suppressing irrelevant visual distractions. More specifically, evening-type individuals managed to suppress a salient distractor in an afternoon testing session, as evidenced by a PD , but were less able to suppress the distractor in a morning testing session, as evidenced by an attenuated PD and a concomitant distractor-elicited N2pc. Morning chronotypes, who would be well past their circadian trough at the time of testing, did not show this deficit at either test time. These results indicate that failure to filter out irrelevant stimuli at an early stage of perceptual processing contributes to impaired cognitive functioning at nonoptimal times of day and may underlie real-world performance impairments, such as distracted driving, that have been associated with circadian mismatch.
- Published
- 2019
19. Classification of marine bioregions on the east coast of South Africa
- Author
-
T-C Livingstone, JM Harris, AT Lombard, AJ Smit, and DS Schoeman
- Abstract
Marine bioregional planning requires a meaningful classification and spatial delineation of the ocean environment using biological and physical characteristics. The relative inaccessibility of much of the ocean and the paucity of directly measured data spanning entire planning regions mean that surrogate data, such as satellite imagery, are frequently used to develop spatial classifications. However, due to a lack of appropriate biological data, these classifications often rely on abiotic variables, which act as surrogates for biodiversity. The aim of this study was to produce a fine-scale bioregional classification, using multivariate clustering, for the inshore and offshore marine environment off the east coast of South Africa, adjacent to the province of KwaZulu-Natal and out to the boundary of the exclusive economic zone (EEZ), 200 nautical miles offshore. We used remotely sensed data of sea surface temperature, chlorophyll a and turbidity, together with interpolated bathymetry and continental-slope data, as well as additional inshore data on sediments, seabed oxygen and bottom temperature. A multivariate k-means analysis was used to produce a fine-scale marine bioregionalisation, with three bioregions subdivided into 12 biozones. The offshore classification was primarily a pelagic bioregionalisation, whereas the inshore classification (on the continental shelf) was a coupled benthopelagic bioregionalisation, owing to the availability of benthic data for this area. The resulting classification was used as a base layer for a systematic conservation plan developed for the province, and provided the methods for subsequent planning conducted for the entire South African EEZ. Validation of the classification is currently being conducted in marine research programmes that are sampling benthic biota and habitats in a sampling design stratified according to the biozones delineated in this study.
- Published
- 2018
- Full Text
- View/download PDF
20. Stability of 3,4-Methylenedioxymethampetamine (MDMA), 4-Methylmethcathinone (Mephedrone) and 3-Trifluromethylphenylpiperazine (3-TFMPP) in Formalin Solution
- Author
-
Jamie Preece, Alexandra K. Cockburn, Derrick J. Pounder, L. Nitin Seetohul, Peter D. Maskell, and Alison C. Livingstone
- Subjects
Quality Control ,Drug ,Analyte ,N-Methyl-3,4-methylenedioxyamphetamine ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,Formaldehyde ,Pharmacology ,Toxicology ,Methylation ,Mass Spectrometry ,Piperazines ,Designer Drugs ,Methamphetamine ,Analytical Chemistry ,chemistry.chemical_compound ,Mephedrone ,Drug Stability ,medicine ,Environmental Chemistry ,Chromatography, High Pressure Liquid ,media_common ,Chemical Health and Safety ,Chromatography ,Chemistry ,Reproducibility of Results ,MDMA ,Hydrogen-Ion Concentration ,Reference Standards ,Diode array ,Serotonin Receptor Agonists ,Solutions ,Calibration ,Hallucinogens ,Indicators and Reagents ,Amine gas treating ,Embalmed body ,medicine.drug - Abstract
Occasionally, the only postmortem samples available for analysis are contaminated with formaldehyde, either due to embalming prior to sampling or because analysis is carried out only when formalin-fixed tissues retained for histological study are available. Formaldehyde reacts with several drugs of forensic interest that contain either a primary or a secondary amine group to form their N-methyl derivatives. We investigated the stability of 3,4-methylenedioxymethampetamine (MDMA), 4-methylmethcathinone (mephedrone) and 3-trifluromethylphenylpiperazine (3-TFMPP) in formalin solutions using three different formaldehyde concentrations (5, 10 and 20%) and three different pHs (3.0, 7.0 and 9.5). Analysis was performed using high-performance liquid chromatography with diode array detection to determine the percentage degradation of each drug over time, up to 60 days. MDMA, mephedrone and 3-TFMPP are unstable in formalin solutions, with the degradation rate increasing with increasing pH. After 28 days in 20% formalin, pH 9.5, there remained 57% of the initial 3-TFMPP concentration, 11% of the initial MDMA concentration and 4% of the initial mephedrone concentration. Forensic toxicologists should be aware that, when analyzing for these drugs in an embalmed body or in tissues stored in formalin solutions, the methylated form of the secondary amine-containing drug could be a more useful analyte than the parent drug.
- Published
- 2013
- Full Text
- View/download PDF
21. Signal enhancement, not active suppression, follows the contingent capture of visual attention
- Author
-
Ashley C. Livingstone, John J. McDonald, Richard D. Wright, and Gregory J. Christie
- Subjects
Adult ,Male ,Visual perception ,genetic structures ,Color vision ,media_common.quotation_subject ,Experimental and Cognitive Psychology ,050105 experimental psychology ,03 medical and health sciences ,Behavioral Neuroscience ,Young Adult ,0302 clinical medicine ,Arts and Humanities (miscellaneous) ,Perception ,Visual attention ,Humans ,0501 psychology and cognitive sciences ,Attention ,Sensory cue ,Evoked Potentials ,media_common ,Cued speech ,Cerebral Cortex ,05 social sciences ,Interval (music) ,Pattern Recognition, Visual ,Visual Perception ,Female ,Cues ,Psychology ,N2pc ,psychological phenomena and processes ,030217 neurology & neurosurgery ,Color Perception ,Cognitive psychology - Abstract
Irrelevant visual cues capture attention when they possess a task-relevant feature. Electrophysiologically, this contingent capture of attention is evidenced by the N2pc component of the visual event-related potential (ERP) and an enlarged ERP positivity over the occipital hemisphere contralateral to the cued location. The N2pc reflects an early stage of attentional selection, but presently it is unclear what the contralateral ERP positivity reflects. One hypothesis is that it reflects the perceptual enhancement of the cued search-array item; another hypothesis is that it is time-locked to the preceding cue display and reflects active suppression of the cue itself. Here, we varied the time interval between a cue display and a subsequent target display to evaluate these competing hypotheses. The results demonstrated that the contralateral ERP positivity is tightly time-locked to the appearance of the search display rather than the cue display, thereby supporting the perceptual enhancement hypothesis and disconfirming the cue-suppression hypothesis. (PsycINFO Database Record
- Published
- 2017
22. Profound changes in miRNA expression during cancer initiation by aflatoxin B
- Author
-
Merricka C, Livingstone, Natalie M, Johnson, Bill D, Roebuck, Thomas W, Kensler, and John D, Groopman
- Subjects
Aflatoxin B1 ,Carcinogenesis ,Liver Neoplasms ,Imidazoles ,Rats, Inbred F344 ,Article ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,Liver ,Carcinogens ,Animals ,Anticarcinogenic Agents ,Oleanolic Acid ,Aspergillus flavus - Abstract
Aflatoxin B1 (AFB1) is a potent human and animal hepatocarcinogen. To investigate the effects of aflatoxin on miRNA expression during the initiation phase of carcinogenesis, next-generation sequencing was used to analyze liver tissues from F344 rats exposed to 200 μg/kg per day AFB1 for 4 weeks. A panel of miRNAs was identified that was upregulated with AFB1 treatment compared to controls: rno-miR-434-3p, rno-miR-411-5p, rno-miR-221-3p, rno-miR-127-3p, rno-miR-205, rno-miR-429, rno-miR-34a-5p, rno-miR-181c-3p, rno-miR-200b-3p, and rno-miR-541-5p. Analysis of rat livers exposed to AFB1 plus the chemopreventive triterpenoid CDDO-Im revealed a striking abrogation of this upregulation. These changes were validated by real-time PCR. We also explored the temporal variation in expression of the candidate miRNAs during the 4-week dosing period. Most of the candidate miRNAs were upregulated at week 1 and increased for the duration of AFB1 dosing over the 4-week period. Treatment with CDDO-Im ameliorated these effects at all time points. All candidate miRNAs were detectable in serum from aflatoxin treated animals; however, there was no significant difference in expression for 7 of the 11 miRNAs examined. Exposure to AFB1 upregulated miR-122-5p (5 fold), 34a-5p (13 fold), and 181c-3p (170 fold) compared with controls. The findings from this study give insight into epigenetic changes induced by aflatoxin taking place during the initial step of carcinogenesis.
- Published
- 2016
23. Abstract 5401: Dysregulated microRNAs in aflatoxin-induced hepatocellular carcinoma: Serum miR-182 as a potential predictive biomarker
- Author
-
Bill D. Roebuck, Thomas W. Kensler, John D. Groopman, Merricka C. Livingstone, and Natalie M. Johnson
- Subjects
Cancer Research ,Aflatoxin ,business.industry ,04 agricultural and veterinary sciences ,medicine.disease ,040401 food science ,Fold change ,Transcriptome ,0404 agricultural biotechnology ,Real-time polymerase chain reaction ,Oncology ,Downregulation and upregulation ,Hepatocellular carcinoma ,microRNA ,Cancer research ,Medicine ,business ,Predictive biomarker - Abstract
Hepatocellular carcinoma (HCC) continues to be a major cause of cancer death globally, with aflatoxin B1 (AFB1) as a prevalent risk factor in low- and middle-income countries. MicroRNAs have been shown to be differentially expressed in HCC and may serve as predictive biomarkers. In this study, we analyzed tumor and non-tumor tissue from rats dosed with AFB1 (200 µg/kg BW) for 28 consecutive days that received vehicle only or AFB1 plus the chemopreventive agent CDDO-Im (30 µmol), and control animals (Johnson et al., CaPR, 2014). Total RNA was isolated from tumor or non-tumor tissue at the time of sacrifice and sequenced. MicroRNA transcriptomic analysis revealed 17 miRNAs significantly upregulated (> 5 fold) in tumors compared to non-tumor tissue. The top ten dysregulated miRNAs determined by fold change and biological significance were selected for further investigation: rno-miR- 205, 200b-3p, 182, 429, 31a-5p, 10b-5p, 141-3p, 132-3p, 802-5p. Validation of sequencing results by quantitative PCR (qPCR) confirmed the upregulation of the majority of candidate miRNAs in tumors and rno-miR-224-5p as the most dysregulated miRNA (over 400 fold). We also examined the levels of these candidates in terminal sera of the same animals by qPCR. Circulating miRs-224-5p, 182, and 122-5p were increased (> 1.5 fold) in animals diagnosed with HCC compared to untreated animals and those previously dosed with AFB1 plus CDDO-Im. Analysis of tracking of serum miR-182 by generalized estimating equations (GEE) revealed significantly increased levels (5 fold; CI: 2.17- 2.50) in animals that developed HCC. This sustained increase in serum miR-182 is seen months before any tumors or other symptoms are present, and highlights this miRNA as a potential predictive biomarker in AFB1-induced HCC. Supported by T32ES007141-31A1 and CA197222. Citation Format: Merricka C. Livingstone, Natalie M. Johnson, Bill D. Roebuck, Thomas W. Kensler, John D. Groopman. Dysregulated microRNAs in aflatoxin-induced hepatocellular carcinoma: Serum miR-182 as a potential predictive biomarker [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5401.
- Published
- 2018
- Full Text
- View/download PDF
24. Searching for inefficiency in visual search
- Author
-
John J. McDonald, Ashley C. Livingstone, and Gregory J. Christie
- Subjects
Male ,genetic structures ,Cognitive Neuroscience ,media_common.quotation_subject ,Object (grammar) ,Neuropsychological Tests ,behavioral disciplines and activities ,Task (project management) ,Young Adult ,Humans ,Relevance (information retrieval) ,Function (engineering) ,Evoked Potentials ,media_common ,Visual search ,Rest (physics) ,Brain ,Electroencephalography ,Visual field ,Visual Perception ,Female ,Psychology ,Inefficiency ,Social psychology ,Photic Stimulation ,Cognitive psychology - Abstract
The time required to find an object of interest in the visual field often increases as a function of the number of items present. This increase or inefficiency was originally interpreted as evidence for the serial allocation of attention to potential target items, but controversy has ensued for decades. We investigated this issue by recording ERPs from humans searching for a target in displays containing several differently colored items. Search inefficiency was ascribed not to serial search but to the time required to selectively process the target once found. Additionally, less time was required for the target to “pop out” from the rest of the display when the color of the target repeated across trials. These findings indicate that task relevance can cause otherwise inconspicuous items to pop out and highlight the need for direct neurophysiological measures when investigating the causes of search inefficiency.
- Published
- 2014
25. Peristylus balakrishnanii (Orchidaceae), a new species from the Andaman archipelago, India
- Author
-
R. Sumathi, K. Karthigeyan, C. Livingstone, and J. Jayanthi
- Subjects
Peristylus ,Plant ecology ,geography ,Orchidaceae ,geography.geographical_feature_category ,biology ,Ecology ,Archipelago ,Botany ,Taxonomy (biology) ,Plant Science ,biology.organism_classification ,Ecology, Evolution, Behavior and Systematics - Abstract
Peristylus balakrishnanii, is described and illustrated from Rutland Island, Andaman Archipelago, India.
- Published
- 2010
- Full Text
- View/download PDF
26. The Addition of a Specialist Pharmacist to Heart Transplant and Ventricular Assist Device Clinics - Early Trends in Patient Care
- Author
-
R.M. Gellatly, C. Livingstone, and P. Bergin
- Subjects
Pulmonary and Respiratory Medicine ,Transplantation ,medicine.medical_specialty ,business.industry ,Ventricular assist device ,medicine.medical_treatment ,Emergency medicine ,Pharmacist ,medicine ,Surgery ,In patient ,Cardiology and Cardiovascular Medicine ,business - Published
- 2015
- Full Text
- View/download PDF
27. Impact of domiciliary pharmacy visits on medication management in an elderly population
- Author
-
C. Livingstone, N. Hodges, Valerie Williamson, and S. Begley
- Subjects
medicine.medical_specialty ,High risk patients ,business.industry ,Health Policy ,Public Health, Environmental and Occupational Health ,Pharmaceutical Science ,Pharmacy ,Patient counselling ,Initial visit ,Elderly population ,Pill ,Physical therapy ,medicine ,Cognitive skill ,Patient compliance ,business - Abstract
This paper describes medication management by elderly patients living in their own homes, and the effects of patient counselling during five domiciliary pharmacy visits on patient compliance and medication management. The 190 subjects who completed the 12-month study were randomly allocated to either an intervention group (receiving counselling on the correct use and storage of their drugs during five domiciliary visits), a control (V) group (receiving visits but no counselling), or a control (NV) group (having no contact between an initial visit and the end of the study). The patients' drug knowledge, dexterity and cognitive functioning were assessed, and patients in all three groups were well matched at baseline. At each follow-up visit, patient compliance was measured using pill counts and interviews. After the initial visit, patients in the intervention group demonstrated better compliance, better drug storage practices and a reduced tendency to hoard drugs, and required fewer GP consultations, than patients in either of the control groups. The provision of the domiciliary pharmacy service was effective in detecting drug-related problems in a potentially high risk patient group. The effectiveness of such a service may be improved by increased transfer of patient information between community pharmacists and general medical practitioners.
- Published
- 1997
- Full Text
- View/download PDF
28. The glucose transporter (GLUT-4) and vesicle-associated membrane protein-2 (VAMP-2) are segregated from recycling endosomes in insulin- sensitive cells
- Author
-
David E. James, Gwyn W. Gould, Judy Tellam, Jan W. Slot, Sally Martin, and C Livingstone
- Subjects
DNA, Complementary ,Monosaccharide Transport Proteins ,Vesicle-Associated Membrane Protein 3 ,Endosome ,Synaptobrevin ,Molecular Sequence Data ,Muscle Proteins ,Transferrin receptor ,Endosomes ,Biology ,Synaptic vesicle ,R-SNARE Proteins ,Mice ,Adipocytes ,Animals ,Insulin ,Amino Acid Sequence ,Cloning, Molecular ,chemistry.chemical_classification ,Glucose Transporter Type 4 ,Base Sequence ,Vesicle ,Glucose transporter ,Membrane Proteins ,Biological Transport ,Cell Biology ,Articles ,3T3 Cells ,Intracellular Membranes ,Sequence Analysis, DNA ,Molecular biology ,Cell biology ,Rats ,chemistry ,Transferrin ,Intracellular - Abstract
Insulin stimulates glucose transport in adipocytes by translocation of the glucose transporter (GLUT-4) from an intracellular site to the cell surface. We have characterized different synaptobrevin/vesicle-associated membrane protein (VAMP) homologues in adipocytes and studied their intracellular distribution with respect to GLUT-4. VAMP-1, VAMP-2, and cellubrevin cDNAs were isolated from a 3T3-L1 adipocyte expression library. VAMP-2 and cellubrevin were: (a) the most abundant isoforms in adipocytes, (b) detectable in all insulin responsive tissues, (c) translocated to the cell surface in response to insulin, and (d) found in immunoadsorbed GLUT-4 vesicles. To further define their intracellular distribution, 3T3-L1 adipocytes were incubated with a transferrin/HRP conjugate (Tf/HRP) and endosomes ablated following addition of DAB and H2O2. While this resulted in ablation of > 90% of the transferrin receptor (TfR) and cellubrevin found in intracellular membranes, 60% of GLUT-4 and 90% of VAMP-2 was not ablated. Immuno-EM on intracellular vesicles from adipocytes revealed that VAMP-2 was colocalized with GLUT-4, whereas only partial colocalization was observed between GLUT-4 and cellubrevin. These studies show that two different v-SNAREs, cellubrevin and VAMP-2, are partially segregated in different intracellular compartments in adipocytes, implying that they may define separate classes of secretory vesicles in these cells. We conclude that a proportion of GLUT-4 is found in recycling endosomes in nonstimulated adipocytes together with cellubrevin and the transferrin receptor. In addition, GLUT-4 and VAMP-2 are selectively enriched in a postendocytic compartment. Further study is required to elucidate the function of this latter compartment in insulin-responsive cells.
- Published
- 1996
29. Abstract 1083: Temporal trends in microRNAs during subchronic aflatoxin dosing and modulation by the chemopreventive oleane triterpenoid, CDDO-Im
- Author
-
Bill D. Roebuck, Natalie M. Johnson, Thomas W. Kensler, Merricka C. Livingstone, and John D. Groopman
- Subjects
Cancer Research ,Aflatoxin ,Cancer ,Biology ,Pharmacology ,medicine.disease ,medicine.disease_cause ,Oncology ,Gene expression ,microRNA ,medicine ,RNA extraction ,Liver cancer ,Carcinogenesis ,Carcinogen - Abstract
Liver cancer is the second leading cause of cancer death worldwide: risk factors include the viruses, HBV and HCV, and the environmental carcinogen aflatoxin B1 (AFB1). Chemoprevention strategies that activate genes controlled by the KEAP1-NRF2 pathway, such as CDDO-Im, afford complete protection against AFB1-induced hepatocarcinogenesis in rats. The opportunity to deploy these types of agents in high-risk populations would be advanced by the validation of biomarkers reflecting their efficacy. MicroRNAs (miRNAs) affecting gene expression are important in normal physiology and have been shown to be frequently dysregulated in cancer. It is our hypothesis that specific rat liver miRNAs are biomarkers that temporally track with AFB1-induced liver cancer, and are modulated in animals that receive complete protection by CDDO-Im. MiRNAs were isolated from archived liver tissue of rats (Johnson et al., CaPR, 2014) that were dosed with AFB1 (200 μg) for 28 consecutive days. Two additional groups received either vehicle only or AFB1 + CDDO-Im (30 μmol). After RNA isolation (miRCURY tissue, Exiqon), samples were profiled by RNA sequencing (Illumina). Fourteen miRNAs were selected based on dynamic range and level of detection for validation by RT-qPCR (TaqMan microRNA assay). MiRNA profiling from animals at the end of the carcinogenic 28-day dosing regimen revealed an increased total number of miRNAs due to AFB1 exposure alone (n≈500) compared to control. Those miRNAs displaying a greater than 10 fold increase in expression between control and AFB1 treatment groups were examined in detail: 541-5p, 34a-5p, 127-3p, 205, 434-3p, 429, 411-5p, 181c-3p, 200b-3p, 221-3p. RNA-seq data showed that these were all upregulated in the AFB1-treated samples. Co-treatment with CDDO-Im shifted expression levels back to control. The miRNAs 192-3p, 92a-3p, 26b-3p, and 375-3p were expressed consistently in all treatment groups and were selected for normalization. Expression levels of the 14 candidate miRNAs were then examined in liver samples obtained from rats after 7, 14 and 21 doses AFB1 and compared to levels determined at week 4 (28 doses AFB1). Quantitative analysis demonstrated an increase in expression of the panel of miRNAs due to AFB1 exposure over the dosing period, potentially indicating a role in early carcinogenesis. MicroRNA expression showed a varying trend over time in animals treated with AFB1 plus CDDO-Im. Three invariant miRNAs (miR-375-3p, 92a-3p, 192-3p) showed little change during the 28-day exposure period. In conclusion, we have identified a panel of miRNAs that are upregulated and track with AFB1 exposure. These changes are abrogated by treatment with CDDO-Im and thus reflect the protective efficacy of the intervention. Supported by T32ES007141-31A1 and CA197222. Citation Format: Merricka C. Livingstone, Bill D. Roebuck, Natalie M. Johnson, Thomas W. Kensler, John D. Groopman. Temporal trends in microRNAs during subchronic aflatoxin dosing and modulation by the chemopreventive oleane triterpenoid, CDDO-Im. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1083.
- Published
- 2016
- Full Text
- View/download PDF
30. Attitudes of pharmacists, medical practitioners and nurses towards the development of domiciliary and other community pharmacy services
- Author
-
N. Hodges, C. Livingstone, S. Begley, and Valerie Williamson
- Subjects
Service (business) ,Professional services ,medicine.medical_specialty ,business.industry ,Health Policy ,education ,Public Health, Environmental and Occupational Health ,Pharmaceutical Science ,Cholesterol monitoring ,Pharmacy ,Patient counselling ,Pain control ,Nursing ,Community pharmacy ,Family medicine ,Medicine ,Medical prescription ,business - Abstract
Surveys were undertaken to determine both the current extent of provision of non-dispensing services by community pharmacists, and pharmacists' attitudes, together with those of medical practitioners and district/practice nurses, towards the development of domiciliary and other community pharmacy services. Five out of a list of 10 professional services were available on the premises in the majority of pharmacies. Approximately 65 per cent of pharmacists undertook prescription collection and medicine delivery and 43 per cent provided domiciliary patient counselling at least once a week. Medical practitioners and nurses expressed high levels of support for the majority of the established services; the exceptions were blood pressure testing and cholesterol monitoring for both of which only 30 per cent of each group were in favour. Most pharmacists were willing, in principle, to train for and to provide a domiciliary service which would include counselling on the use and storage of medicines and the supply or fitting of appliances; support for these services was high among medical practitioners and nurses (85–88 per cent). The proportions of pharmacists who were willing, after training, to provide domiciliary management of total parenteral nutrition, pain control and chemotherapy were 68, 85 and 36 per cent, respectively, but medical practitioners and nurses generally were not in favour of these extended roles. The length of professional registration and frequency of contact with pharmacists were both factors which significantly influenced the level of support by medical practitioners but not by nurses.
- Published
- 1994
- Full Text
- View/download PDF
31. Potential of RADARSAT for Sea ICE Applications
- Author
-
J. Falkingham, B. Ramsay, B. Danielowicz, David G. Barber, T. Hirose, C. Livingstone, R. Gale, M. Manore, M. Shokr, and B. Gorman
- Subjects
Geography ,General Earth and Planetary Sciences ,Humanities ,Cartography - Abstract
RESUMELes periodes ou un bâtiment doit retourner en un lieu donne ainsi que le nombre de jours pendant lequel le bateau est retenu pour le chargement ou le dechargement (jours de starte) imposent des besoins imperieux aux affreteurs navigant dans des eaux couvertes de glaces. Les donnees RADARSAT simulees montrent que ce satellite pourra repondre a la plupart des exigences operationnelles dans le cas d'une “revisite”, en particulier aux latitudes elevees, ou un bateau peut effectuer l'aller-retour dans la meme journee. Les donnees RADARSAT constitueront la principale source d'information, mais elles seront utilisees en conjugaison avec d'autres donnees obtenues par teledetection, de maniere a couvrir tous les besoins des utilisateurs.Pour repondre aux besoins engendres lorsque la starte est de courte duree, il est necessaire de disposer d'un systeme bout en bout, fiable et rapide, pour la reception des signaux, la transformation de l'information pertinente en produits georeferences et l'elaboration d'un r...
- Published
- 1993
- Full Text
- View/download PDF
32. Abstracts of poster presentations
- Author
-
I. Aizpurua, E. Arratibel, K. Aizpuru, Jacques Barthelemy, Jean Chopineau, Stephen Bazire, Nick Beavon, S. Begly, V. Williamson, C. Livingstone, Leif Bergendal, Margareta Ljunggren, S. Clavel, B. Sarrut, C. Doreau, Luengo A. J. Doncel, Garcia M. Pavon, Hákan Emilsson, B. Godman, M. Heyndrickx, H. Clercq, J. E. Houghton, A. Richens, P. A. Routledge, F. J. Woods, J. K. Jibidar, S. Morice, L. Trehaul, M. Duff, H. Krecke, D. Wieczorek, U. Pxokosch, G. Lööf, S. Sjöberg, I. Struwe, Marie E. Maguire, P. F. D'Arcy, Susan H. Rees, G. H. Reuvers, T. A. Galiën, L. T. W. Jong-van den Berg, Cheryl C. Smith, Andrew M. Gillian, P. Tilleul, S. Bergon, J. L. Prugnaud, E. Tomqvist, H. Lyrvall, B. Ohman, and Tony Waite
- Subjects
Pharmacology ,Pharmaceutical Science ,Pharmacology (medical) ,Pharmacy ,General Medicine ,Toxicology - Published
- 1993
- Full Text
- View/download PDF
33. ChemInform Abstract: Probing Structure-Function Relations in Ferritin and Bacterioferritin
- Author
-
Amyra Treffry, J. C. Livingstone, John R. Guest, Peter J. Artymiuk, J. M. A. Smith, Pauline M. Harrison, D. M. Lawson, S J Yewdall, Simon C. Andrews, J. Hirzmann, and G. C. Ford
- Subjects
Ferritin ,Ribonucleotide reductase ,biology ,Biochemistry ,Chemistry ,biology.protein ,Nitrogenase ,General Medicine ,Bacterioferritin ,Nitrate reductase ,Aconitase ,Catechol dioxygenase ,Cofactor - Abstract
Publisher Summary This chapter compares the structures of the iron cores and protein coats of ferritins and the hemoferritins of bacteria, and the current state of knowledge concerning mineralization processes in these molecules is discussed in relation to this structural information. Iron—because of its abundance and versatility—has become an essential element for virtually all forms of life. It is found in enzymes with a variety of functions—for example, ribonucleotide reductase, aconitase, nitrogenase, catechol dioxygenase, acid phosphatase, and procollagen proline hydroxylase and in several of the electron transfer proteins of respiration and photosynthesis. Iron may be the prosthetic group of fumarate nitrate reductase (FNR), a transcriptional regulator for oxygen-dependent gene expression in Escherichia coli. Bacterial ferritin (bacterioferritin) may also be involved in regulating levels of free iron within the cell once the iron has been taken up.
- Published
- 2010
- Full Text
- View/download PDF
34. Radioimmunoassays of Arginine Vasopressin and Atrial Natriuretic Peptide: Application of a Common Protocol for Plasma Extraction Using Sep-Pak C18 Cartridges
- Author
-
E Mulkerrin, D A Oleesky, C Livingstone, D. Hampton, and M D Penney
- Subjects
030213 general clinical medicine ,medicine.medical_specialty ,Vasopressin ,Arginine ,Clinical Biochemistry ,Radioimmunoassay ,Neuropeptide ,030209 endocrinology & metabolism ,Peptide hormone ,03 medical and health sciences ,0302 clinical medicine ,Atrial natriuretic peptide ,Internal medicine ,Methods ,medicine ,Humans ,Chemistry ,Elution ,General Medicine ,Silicon Dioxide ,Arginine Vasopressin ,Endocrinology ,Quantitative analysis (chemistry) ,Atrial Natriuretic Factor ,hormones, hormone substitutes, and hormone antagonists - Abstract
A rapid vacuum-driven procedure, using pre-treated Sep-Pak C18 cartridges, has been developed for the simultaneous extraction of arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) from plasma. Non-specific interference was removed by fractional elution with an aqueous methanol/trifluoroacetic acid (TFA) mixture. AVP and ANP were coeluted under positive pressure with a methanol/TFA mixture and the eluates air-dried before measurement using separate radioimmunoassays. Assay ranges for AVP and ANP were 0·12–29·5 pmol/L and 0·65–162 pmol/L, respectively, with mean recoveries (standard deviation in parentheses) for AVP of 96·4% (5·5%) at a level of 11·8 pmol/L and for ANP of 94·8% (5·9%) at a level of 32·4 pmol/L. The extraction and assay procedures were validated by observing the changes in plasma AVP and ANP concentrations in normal subjects at different stages of hydration and in elderly patients during treatment for congestive cardiac failure.
- Published
- 1992
- Full Text
- View/download PDF
35. Analysis of Geosat Altimeter Sea State Observations and Comparison with S Lmultaneous Aircraft Sar Observations for Norcsex-88
- Author
-
Nelly M. Mognard, Johnny A. Johannessen, Robert A. Shuchman, and C. Livingstone
- Subjects
Synthetic aperture radar ,law ,Radar altimeter ,Radar imaging ,Interferometric synthetic aperture radar ,Sea state ,Altimeter ,Radar ,Geology ,Space-based radar ,Remote sensing ,law.invention - Published
- 2005
- Full Text
- View/download PDF
36. A synthetic moving target generator for calibration of Radarsat 2 Moving-Object Detection Experiment (MODEX)
- Author
-
P. Sevigny, C. Livingstone, and R. Saper
- Subjects
Synthetic aperture radar ,Early-warning radar ,Computer science ,Aperture ,Fire-control radar ,Transponder (aeronautics) ,law.invention ,Radar engineering details ,law ,Radar imaging ,Computer vision ,Radar ,Digital signal processing ,Low probability of intercept radar ,Transponder ,business.industry ,Pulse-Doppler radar ,Side looking airborne radar ,Radar lock-on ,Inverse synthetic aperture radar ,Continuous-wave radar ,Man-portable radar ,Bistatic radar ,3D radar ,Satellite ,Artificial intelligence ,business ,Radar configurations and types - Abstract
The Moving-Object Detection Experiment (MODEX) of the Radarsat 2 platform will allow object motion extraction and measurement by partitioning the radar antenna into fore and aft apertures. Accurate extraction of object motion requires compensation to produce two equivalent radar channels. Calibration of MODEX signals is best accomplished by a transponder that receives and measures the signal transmitted by the satellite and uses the captured radar waveform to generate moving point-target signals with precisely known properties. We are proposing to use a computed approach to implement a synthetic target generator (STG) as a transponder for the motion calibration of Radarsat 2 MODEX. With this approach, the incoming pulses are digitized, manipulated using a fast digital signal processor (DSP) to synthesize signals simulating moving point-targets, and then converted back to analog for transmission. This paper reviews theoretical considerations for the synthesis of moving-object signals, demonstrates the concepts with simulations, and discusses implementation issues.
- Published
- 2002
- Full Text
- View/download PDF
37. SAR-GMTI processing with Canada's Radarsat 2 satellite
- Author
-
T.J. Nohara, P. Weber, C. Livingstone, and A. Premji
- Subjects
Synthetic aperture radar ,Space-time adaptive processing ,Geography ,Early-warning radar ,law ,Clutter ,ComputerApplications_COMPUTERSINOTHERSYSTEMS ,Satellite ,Radar ,Moving target indication ,Space-based radar ,law.invention ,Remote sensing - Abstract
Space-based radar (SBR) has been proposed for various military and civilian applications, including wide area surveillance and theatre defence. Reliable, slow, ground moving target indication (GMTI) of tanks and jeeps, for example, poses a significant challenge, due to strong clutter returns that occupy most, if not all of the available spectrum. Space-time adaptive processing (STAP) techniques can be used to implement radar signal processors capable of providing the required sub-clutter visibility. Despite extensive research studies, at present no space-based GMTI systems are in operation. Canada and the United States are presently conducting experimental programs that will include the launching of space-based radar systems capable of synthetic aperture radar (SAR) and GMTI modes. This paper reports on Canada's Radarsat 2 GMTI mode and provides a preliminary analysis of SAR-GMTI performance based on computer simulations.
- Published
- 2002
- Full Text
- View/download PDF
38. The constructor's experience: the designers response
- Author
-
C Livingstone
- Subjects
Computer science ,Programming language ,computer.software_genre ,computer - Published
- 2002
- Full Text
- View/download PDF
39. Why don't more women report sexual assault to the police?
- Author
-
M J, McGregor, E, Wiebe, S A, Marion, and C, Livingstone
- Subjects
Self Disclosure ,British Columbia ,Rape ,Research ,Humans ,Female ,Police - Published
- 2000
40. Adaptive Compensation of RADARSAT SAR Analoque-to-Digital Converter Saturation Power Loss
- Author
-
A P Luscombe, A L Gray, C Livingstone, and P W Vachon
- Subjects
Power loss ,Control theory ,Environmental science ,Saturation (chemistry) ,Digital converter ,Compensation (engineering) - Published
- 1997
- Full Text
- View/download PDF
41. Geoscience Applications with Polarimetric SAR
- Author
-
R S Brown, S Paterson, B Brisco, and C Livingstone
- Subjects
Polarimetric sar ,Geology ,Remote sensing - Published
- 1996
- Full Text
- View/download PDF
42. ATF-2 contains a phosphorylation-dependent transcriptional activation domain
- Author
-
Nicholas C. Jones, Gunvanti Patel, and C. Livingstone
- Subjects
Transcription, Genetic ,Proto-Oncogene Proteins c-jun ,Ultraviolet Rays ,viruses ,CHO Cells ,Biology ,Mitogen-activated protein kinase kinase ,CREB ,DNA-binding protein ,environment and public health ,General Biochemistry, Genetics and Molecular Biology ,Structure-Activity Relationship ,Cricetinae ,Animals ,Phosphorylation ,Cyclic AMP Response Element-Binding Protein ,Molecular Biology ,Transcription factor ,Mitogen-Activated Protein Kinase Kinases ,General Immunology and Microbiology ,Activating Transcription Factor 2 ,Kinase ,General Neuroscience ,fungi ,JNK Mitogen-Activated Protein Kinases ,DNA-binding domain ,Activating transcription factor 2 ,Recombinant Proteins ,Cell biology ,Biochemistry ,Enzyme Induction ,Calcium-Calmodulin-Dependent Protein Kinases ,biology.protein ,Adenovirus E1A Proteins ,Mitogen-Activated Protein Kinases ,Protein Kinases ,Signal Transduction ,Transcription Factors ,Research Article - Abstract
The ATF-2 transcription factor can mediate adenovirus E1A-inducible transcriptional activation. Deletion analysis has indicated that the N-terminal region of ATF-2 is essential for this response. Furthermore, the N-terminus can activate transcription in the absence of E1A when fused to a heterologous DNA binding domain. However, in the intact protein this activation domain is masked. In this report we show that residues in the N-terminus required for activation are also required for mediating E1A stimulation. In particular two threonine residues at positions 69 and 71 are essential. These residues are phosphorylated in vivo and can be efficiently phosphorylated in vitro by the JNK/SAPK subgroup of the MAPK family. ATF-2 can bind to a UV-inducible kinase through a region in the N-terminus that is distinct from the sites of phosphorylation; this binding region is both necessary for phosphorylation by JNK/SAPK in vitro and for transcriptional activation in vivo. The activity of the N-terminus is stimulated by UV irradiation which stimulates the signalling pathway leading to JNK/SAPK. Finally, although ATF-2 binds to the E1A protein, the N-terminal activation domain is not required for this interaction. The results show that ATF-2, like other members of the ATF/CREB family of DNA binding proteins is regulated by specific signalling pathways.
- Published
- 1995
43. Insulin resistance in diabetes mellitus. Defective insulin-regulatable glucose transport plays an important role
- Author
-
C, Livingstone and G W, Gould
- Subjects
Glucose Transporter Type 4 ,Adipose Tissue ,Diabetes Mellitus, Type 2 ,Monosaccharide Transport Proteins ,Humans ,Muscle Proteins ,Insulin Resistance ,Muscle, Skeletal - Published
- 1995
44. Checklist of orchids from a mid elevation evergreen forest at Kakachi-Kodayar, Kalakkad-Mundanthurai Tiger Reserve, Agasthyamalai, southern Western Ghats
- Author
-
C. Livingstone and R. Ganesan
- Subjects
Bamboo ,Geography ,biology ,Tiger ,Agroforestry ,Range (biology) ,Ochlandra ,Logging ,Subtropics ,Evergreen ,biology.organism_classification ,Evergreen forest - Abstract
The forests at Kakachi-Kodayar (77o 24’N & 8o 32’E, 1200-1550m), in Kalakad-Mundanthurai Tiger Reserve, part of Agasthyamalai range in the southern part of the Western Ghats (see map) support one of the species-rich forest site (Ganesh et al., 1996).Though some part of the forest is lost to the dam, plantations, logging and Ochlandra spp. (reed bamboo) extraction, it still supports dense contiguous forest of subtropical wet evergreen, subtropical montane and shola forest types surrounded by grasslands.
- Published
- 2001
- Full Text
- View/download PDF
45. Probing Structure-Function Relations In Ferritin And Bacterioferritin
- Author
-
Peter J. Artymiuk, S J Yewdall, Amyra Treffry, G. C. Ford, D. M. Lawson, Pauline M. Harrison, John R. Guest, J. C. Livingstone, J. M. A. Smith, Simon C. Andrews, and J. Hirzmann
- Subjects
Ferritin ,Ribonucleotide reductase ,biology ,Biochemistry ,Chemistry ,biology.protein ,Nitrogenase ,Bacterioferritin ,Nitrate reductase ,Aconitase ,Cofactor ,Catechol dioxygenase - Abstract
Publisher Summary This chapter compares the structures of the iron cores and protein coats of ferritins and the hemoferritins of bacteria, and the current state of knowledge concerning mineralization processes in these molecules is discussed in relation to this structural information. Iron—because of its abundance and versatility—has become an essential element for virtually all forms of life. It is found in enzymes with a variety of functions—for example, ribonucleotide reductase, aconitase, nitrogenase, catechol dioxygenase, acid phosphatase, and procollagen proline hydroxylase and in several of the electron transfer proteins of respiration and photosynthesis. Iron may be the prosthetic group of fumarate nitrate reductase (FNR), a transcriptional regulator for oxygen-dependent gene expression in Escherichia coli. Bacterial ferritin (bacterioferritin) may also be involved in regulating levels of free iron within the cell once the iron has been taken up.
- Published
- 1991
- Full Text
- View/download PDF
46. Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts
- Author
-
Peter J. Artymiuk, J. C. Livingstone, Gianni Cesareni, Sonia Levi, Pauline M. Harrison, D. M. Lawson, Paolo Arosio, Alessandra Luzzago, Christopher Thomas, J. M. A. Smith, S J Yewdall, William V. Shaw, Amyra Treffry, Lawson, D. M., Artymiuk, P. J., YEWDALL S., J, Livingstone, J. C., Treffry, A, Luzzago, A., Levi, SONIA MARIA ROSA, Arosio, P., Cesareni, G., and Harrison, P.
- Subjects
EXPRESSION ,Models, Molecular ,Iron ,CONSERVATION ,Molecular Sequence Data ,Sequence (biology) ,Ferroxidase activity ,Metal ,X-Ray Diffraction ,HORSE SPLEEN APOFERRITIN ,Computer Graphics ,Molecule ,Animals ,Humans ,PSEUDOGENE ,SUBUNIT GENE ,Amino Acid Sequence ,Binding site ,Multidisciplinary ,Binding Sites ,Crystallography ,IDENTIFICATION ,biology ,Intermolecular force ,Bacterioferritin ,ESCHERICHIA-COLI ,CHAIN FERRITINS ,IRON ,RESOLUTION ,Recombinant Proteins ,Rats ,Ferritin ,Molecular Weight ,Settore BIO/18 - Genetica ,visual_art ,Ferritins ,biology.protein ,visual_art.visual_art_medium - Abstract
FERRITINis important in iron homeostasis. Its twenty-four chains of two types, H and L, assemble as a hollow shell providing an iron-storage cavity1–3. Ferritin molecules in cells containing high levels of iron tend to be rich in L chains, and may have a long-term storage function, whereas H-rich ferritins are more active in iron metabolism3–7. The molecular basis for the greater activity of H-rich ferritins has until now been obscure, largely because the structure of H-chain ferritin has remained unknown owing to the difficulties in obtaining crystals ordered enough for X-ray crys-tallographic analysis. Here we report the three-dimensional structure of a human ferritin H-chain homopolymer. By genetically engineering a change in the sequence of the intermolecular contact region, we obtained crystals isomorphous with the homologous rat L ferritin8–9 and of high enough quality for X-ray diffraction analysis. The X-ray structure of human H ferritin shows a novel metal site embedded within each of its four-helix bundles and we suggest that ferroxidase activity associated with this site accounts for its rapid uptake of iron10.
- Published
- 1991
47. W12-P-021 Relationship between plasma antibody titres to heat shock proteins-60,-65 and -70, CRP and traditional coronary risk factors including metabolic syndrome
- Author
-
Gordon A. Ferns, T. Wang, C. Livingstone, Majid Ghayour-Mobarhan, David J. Lamb, Nandita Vaidya, and D.J. Lovel
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Coronary risk factors ,General Medicine ,medicine.disease ,Endocrinology ,Internal medicine ,Heat shock protein ,Immunology ,Internal Medicine ,medicine ,biology.protein ,Metabolic syndrome ,Antibody ,Cardiology and Cardiovascular Medicine ,business - Published
- 2005
- Full Text
- View/download PDF
48. M.522 Antibody titres to heat shock protein 60, 65 and 70 are elevated in dyslipidaemic patients with established CHD
- Author
-
Gordon A. Ferns, David J. Lamb, C. Livingstone, and Majid Ghayour-Mobarhan
- Subjects
medicine.medical_specialty ,Endocrinology ,biology ,business.industry ,Internal medicine ,Heat shock protein ,Internal Medicine ,medicine ,biology.protein ,General Medicine ,Antibody ,Cardiology and Cardiovascular Medicine ,business - Published
- 2004
- Full Text
- View/download PDF
49. The Age of the Arctic: Hot Conflicts and Cold Realities. By Gail Osherenko and Oran R. Young. Cambridge: Cambridge University Press, 1989. 316p. $59.50
- Author
-
Augustus Richard Norton, Mehran Tamadonfar, Neil C. Livingstone, David Halevy, and Martin H. Greenberg
- Subjects
International relations ,Spanish Civil War ,Sociology and Political Science ,Covert ,Law ,Political science ,Political Science and International Relations ,Palestine - Published
- 1991
- Full Text
- View/download PDF
50. Separation of ifosfamide and its degradation products using micellar electrokinetic chromatography
- Author
-
Shannon Hill, P. E. Kavanagh, Peter C. Livingstone, John Aexiou, James Soscic, and Ross Andrew Shalliker
- Subjects
Peak area ,Ifosfamide ,Chromatography ,Resolution (mass spectrometry) ,Chemistry ,Analytical chemistry ,Reversed-phase chromatography ,Micellar electrokinetic chromatography ,Analytical Chemistry ,medicine ,Degradation (geology) ,Uv detection ,Quantitative analysis (chemistry) ,medicine.drug - Abstract
Ifosfamide and its thermal degradation products were separated using micellar electrokinetic chromatography (MEKC). The method was compared with a published reversed phase HPLC method. Much better resolution was obtained using the MEKC method. Nine degradation products could be detected using MEKC compared with only two using reversed phase HPLC. The LOD using the equipment described was 0.05 mg ml–1 with UV detection at 185 mm. The standard error of the peak area for five injections was 2.8%. The standard error of peak position of the degradation products varied from less than 1% up to 5% with the latter eluting peaks having the higher variation.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.